<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64522</article-id><article-id pub-id-type="doi">10.7554/eLife.64522</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Physics of Living Systems</subject></subj-group></article-categories><title-group><article-title>Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-214015"><name><surname>Chauhan</surname><given-names>Lakshya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5851-507X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-214016"><name><surname>Ram</surname><given-names>Uday</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-214017"><name><surname>Hari</surname><given-names>Kishore</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-131244"><name><surname>Jolly</surname><given-names>Mohit Kumar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6631-2109</contrib-id><email>mkjolly@iisc.ac.in</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Centre for BioSystems Science and Engineering, Indian Institute of Science</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff><aff id="aff2"><label>2</label><institution>Undergraduate Programme, Indian Institute of Science</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Walczak</surname><given-names>Aleksandra M</given-names></name><role>Senior Editor</role><aff><institution>École Normale Supérieure</institution><country>France</country></aff></contrib><contrib contrib-type="editor"><name><surname>Krishna</surname><given-names>Sandeep</given-names></name><role>Reviewing Editor</role><aff><institution>National Centre for Biological Sciences‐Tata Institute of Fundamental Research</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e64522</elocation-id><history><date date-type="received" iso-8601-date="2020-11-01"><day>01</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-03-16"><day>16</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Chauhan et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Chauhan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64522-v2.pdf"/><abstract><p>Phenotypic (non-genetic) heterogeneity has significant implications for the development and evolution of organs, organisms, and populations. Recent observations in multiple cancers have unraveled the role of phenotypic heterogeneity in driving metastasis and therapy recalcitrance. However, the origins of such phenotypic heterogeneity are poorly understood in most cancers. Here, we investigate a regulatory network underlying phenotypic heterogeneity in small cell lung cancer, a devastating disease with no molecular targeted therapy. Discrete and continuous dynamical simulations of this network reveal its multistable behavior that can explain co-existence of four experimentally observed phenotypes. Analysis of the network topology uncovers that multistability emerges from two teams of players that mutually inhibit each other, but members of a team activate one another, forming a ‘toggle switch’ between the two teams. Deciphering these topological signatures in cancer-related regulatory networks can unravel their ‘latent’ design principles and offer a rational approach to characterize phenotypic heterogeneity in a tumor.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>multistability</kwd><kwd>phenotypic heterogeneity</kwd><kwd>network topology</kwd><kwd>design principles</kwd><kwd>toggle switch</kwd><kwd>small cell lung cancer</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001843</institution-id><institution>Science and Engineering Research Board</institution></institution-wrap></funding-source><award-id>SB/S2/RJN-049/2018</award-id><principal-award-recipient><name><surname>Jolly</surname><given-names>Mohit Kumar</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Network topology and gene expression patterns in small cell lung cancer reveal two mutually opposing teams of regulators that enable multistability and consequent non-genetic heterogeneity, a clinically unsolved challenge.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>‘Genotype controls phenotype’ has been a prevalent paradigm across multiple biological contexts (<xref ref-type="bibr" rid="bib47">Orgogozo et al., 2015</xref>). However, past few decades have revealed in many biological organisms that a fraction of cells in a genetically identical population can behave differently from others, even under nearly identical environmental conditions. This ‘phenotypic heterogeneity’ usually refers to ‘non-genetic’ variations among individual cells in a genetically homogeneous scenario (<xref ref-type="bibr" rid="bib23">Grote et al., 2015</xref>). In microbial populations, this heterogeneity can manifest as variation in morphologies, growth dynamics, metabolic signatures, and response to antibiotics. It can enable ‘bet-hedging’, thereby providing cell populations or organisms with higher fitness especially in fluctuating environments (<xref ref-type="bibr" rid="bib1">Ackermann, 2015</xref>). Another advantage of phenotypic heterogeneity is division of labor and the possibility of cooperation among phenotypically distinct subpopulations (<xref ref-type="bibr" rid="bib3">Armbruster et al., 2019</xref>). Phenotypic heterogeneity is an evolvable trait and can, in turn, shape evolutionary trajectories at genomic levels too, as seen in bacteria, yeast (<xref ref-type="bibr" rid="bib7">Bódi et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">van Boxtel et al., 2017</xref>), and more recently in cancer cell populations (<xref ref-type="bibr" rid="bib57">Salgia and Kulkarni, 2018</xref>). Therefore, decoding mechanistic underpinnings of emergence of phenotypic heterogeneity remains crucial.</p><p>Two generic mechanisms proposed for phenotypic heterogeneity are stochastic gene expression and multistability. Stochastic fluctuations in levels of various biomolecules can trigger the cells to reversibly switch their phenotypes, with important functional implications in tolerance to antibiotics (<xref ref-type="bibr" rid="bib5">Balaban et al., 2004</xref>), in enabling the latency of HIV (<xref ref-type="bibr" rid="bib77">Weinberger et al., 2005</xref>), and in long-term resistance to anticancer drugs (<xref ref-type="bibr" rid="bib32">Inde and Dixon, 2018</xref>; <xref ref-type="bibr" rid="bib53">Ramirez et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Sharma et al., 2010</xref>), highlighting common principles of population behavior across living systems (<xref ref-type="bibr" rid="bib6">Ben-Jacob et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Jolly et al., 2018</xref>). Cancer has been largely thought of as a genetic disease driven by accumulated mutations in key oncogenes and tumor suppressor genes involved in hallmarks of cancer such as increased proliferation and decreased cell death (<xref ref-type="bibr" rid="bib25">Hanahan and Weinberg, 2011</xref>). Thus, evolution in cancer has been mostly postulated as a Darwinian process of clonal selection (<xref ref-type="bibr" rid="bib80">Wooten and Quaranta, 2017</xref>), therefore promoting gathering of resource-heavy data through international consortiums such as The Cancer Genome Atlas (TCGA) or International Genome Cancer Consortium (ICGC) primarily at a genomic level. However, increasing evidence has shown that a cancer cell’s phenotype is not solely driven by its genotype (<xref ref-type="bibr" rid="bib9">Brock et al., 2009</xref>; <xref ref-type="bibr" rid="bib27">Hu et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Sharma et al., 2019</xref>) and that non-genetic mechanisms such as stochastic gene expression and/or multistability can propel metastasis (<xref ref-type="bibr" rid="bib37">Jolly and Celià-Terrassa, 2019</xref>; <xref ref-type="bibr" rid="bib38">Lee et al., 2014</xref>) and resistance to various therapies (<xref ref-type="bibr" rid="bib43">Meyer et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Miura et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Mohanty et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Pisco et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Shaffer et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Spencer et al., 2009</xref>; <xref ref-type="bibr" rid="bib68">Su et al., 2019</xref>) – the two major unsolved clinical challenges in cancer. Consistently, no unique mutational signature has been yet identified for metastasis; instead, phenotypic adaptability is considered to be a hallmark of metastasis (<xref ref-type="bibr" rid="bib13">Celià-Terrassa and Kang, 2016</xref>; <xref ref-type="bibr" rid="bib78">Welch and Hurst, 2019</xref>). Therefore, it is essential to investigate the emergent dynamics of regulatory networks that can give rise to multistability and consequently accelerate tumor aggressiveness.</p><p>Here, we elucidate the dynamics of a regulatory network underlying phenotypic heterogeneity in small cell lung cancer (SCLC) – a highly metastatic cancer that accounts for 15% of all lung cancer cases, has a 7% five year survival rate, has no molecular targeted therapy, and shows rapid relapse to a treatment-refractory phase after initial response to chemotherapy and radiotherapy that remains to be the standard of care for SCLC for over half a century. Therefore, SCLC has been placed in the category of recalcitrant cancers (<xref ref-type="bibr" rid="bib20">Gazdar et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>). Nearly all SCLC cases show genomic inactivation of TP53 and RB1 (<xref ref-type="bibr" rid="bib21">George et al., 2015</xref>); thus, phenotypic heterogeneity observed in SCLC cannot be explained based on the mutational status (<xref ref-type="bibr" rid="bib54">Rudin et al., 2019</xref>). Here, we demonstrate that phenotypic heterogeneity in SCLC can be explained by simulating the dynamics of a regulatory network underlying SCLC using both continuous and discrete modeling approaches. The four predominant phenotypes that this network enables can be mapped on to recently identified molecular subtypes of SCLC – ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>, ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>, ASCL1<sup>high</sup>/NEUROD1<sup>high</sup>, and ASCL1<sup>low</sup>/NEUROD1<sup>low</sup>. Further analysis of SCLC network topology reveals that multistability in this complex network of 33 nodes and 357 edges emerges due to two teams of players in the network that are operating against one another – players of both teams tend to activate and be activated by members of the same team, while they inhibit and are inhibited by members of the other team, thus forming an effective ‘toggle switch’ between the two teams. Intriguingly, this topological signature trait is specific to this SCLC regulatory network; perturbing the network disrupts this signature and leads to disappearance of these four phenotypes. Furthermore, data analysis shows that ASCL1<sup>low</sup>/NEUROD1<sup>low</sup> subtype can be sub-classified into ASCL1<sup>low</sup>/NEUROD1<sup>low</sup>/YAP1<sup>low</sup>/POU2F3<sup>high</sup> and ASCL1<sup>low</sup>/NEUROD1<sup>low</sup>/YAP1<sup>high</sup>/POU2F3<sup>low</sup> classes. Together, our results unravel the latent design principles of the complex SCLC regulatory network and offer a rational framework to decode the phenotypic heterogeneity in SCLC through the lens of network topology.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Discrete and parameter-agnostic continuous simulations of the SCLC network result in similar phenotypic distributions</title><p>We simulated the emergent dynamics of a SCLC master regulatory network constructed from gene expression signatures, which contained 33 nodes and 357 edges (<xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). To obtain the steady-state (i.e. phenotypic) distributions corresponding to this complex network, we implemented two complementary approaches – one of them is a discrete parameter-independent Boolean modeling approach using Ising model formalism and an asynchronous update mode (<xref ref-type="bibr" rid="bib17">Font-Clos et al., 2018</xref>), and the other is RACIPE (Random Circuit Perturbation) (<xref ref-type="bibr" rid="bib29">Huang et al., 2017</xref>), a parameter-agnostic approach that uses a set of coupled ordinary differential equations (ODEs) with parameters sampled over a wide biologically relevant range.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Dynamic simulations of SCLC network.</title><p>(<bold>A</bold>) SCLC regulatory network, in which green nodes denote activation and red nodes denote inhibitory interaction. (<bold>B</bold>) Steady states achieved from asynchronous Boolean update, using Ising model and 2<sup>20</sup> initial conditions (for results corresponding to 2<sup>25</sup> initial conditions, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Each row is a steady state, and each column is a node in the network. Dark cells represent node ‘off’ (0) and blank ones represent node ‘on’ (1). The frequency of each state is reported to the left of each row in percentage as mean ± standard deviation over three replicates. (<bold>C</bold>) (i–ii) Schematic representing edge swapping strategy for network randomization, where (ii) is a randomized network for the ‘wild-type’ (WT) network (i). (iii) Distribution of number of steady states for 1000 randomized networks corresponding to SCLC WT network. Red line shows the number of states obtained for the SCLC WT network. (<bold>D</bold>) (i) Comparison of steady-state frequencies obtained via RACIPE and Boolean. The frequency of four dominant states obtained in Boolean (X1–X4) is shown in yellow bars. The other three bars show the frequency of RACIPE states identical to corresponding Boolean states (distance = 0) and the cumulative frequency of states which are less than or equal to n nodes having different values (node value = 0 in RACIPE and 1 in Boolean or vice versa) (distance = 1, 2). Results over three replicates are reported as mean ± standard deviation (error bars). (ii) Correlation plot between Jensen–Shannon divergence (JSD) for the case of edge deletion and JSD for the case of reverting the sign of the corresponding edge. Each dot denotes an edge that has been perturbed. Inset shows zoomed-in view for the highlighted small box. The mean and standard deviation of Pearson’s coefficient correlation values for this scatter plot, over three replicates, is 0.851 ± 0.003.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig1-v2.tif"/></fig><p>In the Ising model formalism, each state is represented as a Boolean vector of N elements, where N (=33 here) is the number of nodes in the networks. Based on randomly chosen set of initial conditions (n = 2<sup>20</sup> here), multiple simulations capture the ensemble of steady states obtained. The discrete-time asynchronous network dynamics considered here is simulated via<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo> <mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:munder><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo> </mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:munder><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:munder><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow> </mml:mrow></mml:mrow></mml:math></disp-formula>where s<sub>i</sub> (t) denotes the expression levels of node <italic>i</italic> at time <italic>t</italic>. s<sub>i</sub> = +1 means that the node is highly expressed (i.e. ‘ON’ state), otherwise s<sub>i</sub> = −1. M depicts the interaction matrix of the network. M<sub>ij</sub> = 1 indicates that node <italic>i</italic> promotes the expression of node <italic>j</italic>, M<sub>ij </sub>= −-1 implies that node <italic>i</italic> inhibits the expression of node <italic>j</italic>, M<sub>ij</sub> = 0 implies no regulatory interaction from node <italic>i</italic> to node <italic>j</italic>.</p><p>For this network, we obtained 10 unique steady states, among which four of them (X1–X4) had a frequency of 24.3–25.5% each, while the remaining six states (X5–X10) had frequency less than 0.1% (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To characterize these steady states further, we calculate the frustration of each state, which, using the analogy of asymmetric spin glass on a graph, is defined as the fraction of network edges that are frustrated in that state. An edge from node <italic>i</italic> to node <italic>j</italic> is said to be frustrated in the state {<italic>s<sub>i</sub></italic>} if M<sub>ij</sub>s<sub>i</sub>s<sub>j</sub> &lt; 0, i.e. if the values of node <italic>i</italic> and node <italic>j</italic> do not follow the set of regulatory interactions between them. As expected, states with high frequency (~24.3–25.5% each) had low frustration (0.14) and those with lower frequency (&lt;0.1% each) have higher frustration (0.37) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>, <xref ref-type="bibr" rid="bib72">Tripathi et al., 2020b</xref>).</p><p>To understand the role of network topology of the SCLC network in enabling these steady states, we perturbed the network topology by picking up random pairs of edges and swapping them (<xref ref-type="fig" rid="fig1">Figure 1C,i,ii</xref>). This process is repeated for many iterations to ensure that the resultant network (referred to as the random network(s) henceforth), is very different from the original SCLC network (referred to as the ‘wild-type’ [WT] network henceforth). We created 1000 such random networks and simulated them using the above-mentioned Ising model formalism. Importantly, a majority of these networks gave rise to a much larger number (i.e. 10<sup>4</sup>–10<sup>6</sup>) of steady states as compared to the WT network (<xref ref-type="fig" rid="fig1">Figure 1C,iii</xref>). Furthermore, none of these steady-state distributions obtained from random networks had any overlap with the steady-state distribution of WT network, suggesting that the steady-state distribution of WT network is unique to its topology.</p><p>To gain further confidence in the role of network topology in enabling the steady-state distribution of WT network, we used RACIPE that generates an ensemble of kinetic models (set of coupled ODEs) corresponding to a network topology, each with a different set of parameters sampled uniformly from a wide but biologically relevant parameter space. Each kinetic model is simulated using an ODE solver to obtain different steady states obtainable from different initial conditions. We generated 10<sup>6</sup> models and simulated each of them with 1000 initial conditions, from which we obtained the ensemble of steady states and discretized them (see Materials and methods) to obtain a distribution that can be compared with the output obtained from a Boolean modeling framework. RACIPE enables a much larger number of states as compared to Boolean, which is not surprising given its continuous nature. The net frequency of the X1–X4 states obtained via RACIPE is 22%. However, all of the top 20 states obtained by RACIPE were close enough to one or more of the top four Boolean states (X1–X4); there were a maximum of 2 of 33 nodes whose values were different (0 in Boolean state and 1 in RACIPE state or vice versa). These top 20 states contribute to a total of 54% frequency of all steady-states identified by RACIPE (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). This minor difference observed in state compositions prompted us to a more quantitative comparison. We calculated the net frequency of states that have only one or two node values different than that seen in corresponding Boolean state (X1–X4). The total frequency of RACIPE state, together with its ‘close-enough’ states, was similar to that of corresponding Boolean states (<xref ref-type="fig" rid="fig1">Figure 1D,i</xref>), thus endorsing a consistency in gene expression programs identified by Boolean and RACIPE models. This similarity between RACIPE and Boolean outputs reinforces that network topology has a crucial role in enabling the resultant steady-state distributions of the SCLC network.</p><p>Next, we investigated the resilience of the WT SCLC network by generating two types of ‘mutant’ networks. Each ‘mutant’ network has an edge either deleted or its sign reversed (from activation to inhibition and vice versa). Thus, we had 2*357 = 714 such ‘mutant’ or ‘perturbed’ networks for which we calculated the steady-state distributions using the Ising model (2<sup>20</sup> initial conditions). To quantify the degree of similarity between the steady-state distributions of WT SCLC network and that of a ‘perturbed’ network, we used an information-theory metric known as Jensen–Shannon divergence (JSD), which ranges from 0 to 1 (<xref ref-type="bibr" rid="bib39">Lin, 1991</xref>). JSD = 0 indicates identical distributions, and JSD = 1 indicates completely non-overlapping ones. As a control, JSD = 1 was obtained for all 1000 random networks with respect to the WT network, given that there is no overlap of states. Intriguingly, we observed that most single-edge mutations (deletions or sign reversal) had a negligible effect on dynamics of the WT SCLC network (JSD &lt; 0.01 for 678 of 714 perturbed networks). Also, the JSD values of mutated networks with either change correlated well (<xref ref-type="fig" rid="fig1">Figure 1D,ii</xref>), suggesting a consistent contribution of the edge mutated in enabling steady-state distributions of the SCLC network. Importantly, among the 36 edge perturbations that led to a higher JSD, i.e. disturbed the frequency distribution, 24 of them were incoming edges for NEUROD1 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). This observation suggests that NEUROD1 can play a key role in maintaining the robustness of SCLC network dynamics and subsequently in enabling phenotypic heterogeneity. Put together, these results revealed that the SCLC network is quite resilient to single-edge perturbations and suggests the possibility of multiple layers of redundancy or reinforcement in the SCLC network to enable this specific steady-state distribution.</p></sec><sec id="s2-2"><title>Similarity between simulation and SCLC experimental data based on node correlations</title><p>To investigate the degree of resilience or reinforcement within the SCLC network, we performed pairwise correlation between all 33 nodes in the network. Strikingly, based on the top four states obtained from Boolean simulation of the WT network, we observed that 32 of 33 nodes formed two groups of nodes, such that within a group, the nodes were positively correlated, but across the groups, each pairwise correlation was negative (all nodes except NEUROD1; <xref ref-type="fig" rid="fig2">Figure 2A,i</xref>). Therefore, the network seemed to form two competing ‘teams’ or groups of players. Interestingly, one of the groups (top triangle in <xref ref-type="fig" rid="fig2">Figure 2A,i</xref>; called as group A henceforth) contained ASCL1, INSM1, FOXA1, and FOXA2, all of which are implicated in neuro-endocrine phenotype(s) in SCLC. On the other hand, the other group (lower triangle in <xref ref-type="fig" rid="fig2">Figure 2A,i</xref>; called as group B henceforth) contained REST, SMAD3, and ZEB1 are suggested markers/regulators of non-neuroendocrine (NE) or mesenchymal subtype(s) of SCLC (<xref ref-type="bibr" rid="bib8">Borromeo et al., 2016</xref>; <xref ref-type="bibr" rid="bib70">Tlemsani et al., 2020</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of two ‘teams’.</title><p>(<bold>A</bold>) (i) Pearson’s correlation matrix for Boolean simulations of WT SCLC network. Each node represents the correlation coefficient for pairwise correlations, as shown in adjacent colormap. (ii) Distribution of the values of J metric for 1000 random networks for Boolean simulations. Red dotted line shows the value of J (=496) for Boolean simulations (<bold>A, i</bold>); blue dotted line shows the same (J = 373.05) for RACIPE simulations (<bold>B</bold>, i). (<bold>B</bold>) (i) Same as (<bold>A</bold>, i) but for RACIPE simulations. (ii) Same as (<bold>B</bold>, ii) but for cases when Pearson’s correlation coefficient values are sampled continuously from [−1,1]. Red dotted line shows the value of J for wild-type Boolean (<bold>A</bold>, i) and blue dotted line shows the value of J for Wild-type RACIPE (<bold>B</bold>, i). Black and green dotted lines show the value of J for CCLE (<bold>C, i</bold>) and GSE73160 (<bold>C</bold>, ii). (<bold>C</bold>) Same as (<bold>A</bold>, <bold>i</bold>) but for CCLE (i) and GSE73160 (ii). Details of indices 1–33 are available in the rightmost table.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig2-v2.tif"/></fig><p>We defined a metric J to quantify the cumulative strength of relationship among different nodes in the network, which quantifies the degree of similarity in the two ‘teams’ and mutual competition among them.<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>J</mml:mi><mml:mo>=</mml:mo><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>22</mml:mn></mml:mrow></mml:munderover><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>33</mml:mn></mml:mrow></mml:munderover><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>33</mml:mn></mml:mrow></mml:munderover><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>22</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p>Here, P denotes the correlation matrix, and P<sub>ij</sub> denotes Pearson’s correlation coefficient between node <italic>i</italic> and node <italic>j</italic>; the key to the indices is given in table shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. For correlation matrix obtained for Boolean simulations for the WT network, the coefficient values are either 1 or −1, and the value of J metric is calculated to be 496. However, for the 1000 random networks, the values of J are quite small; the average value of J across 1000 networks is 11 (<xref ref-type="fig" rid="fig2">Figure 2A,ii</xref>), thus suggesting that this metric can be a quantitative method to distinguish between WT and random networks and that this observed feature of two ‘teams’ of players is unique to the WT topology.</p><p>Similar trends of two ‘teams’ were seen in RACIPE simulation data (<xref ref-type="fig" rid="fig2">Figure 2B,i</xref>), albeit the value of J was lower (=373.05), largely because the values of Pearson’s correlation coefficients for all (non-discretized) RACIPE pairwise comparisons will lie between −1 and +1 on a spectrum, instead of discretized values of −1 and +1 seen for Boolean simulations. For a fairer comparison, we recalculated the value of J metric for 1000 random networks now using continuous values of P<sub>ij</sub> (see Materials and methods). The mean value of J obtained from these 1000 networks was 14.16, a value much smaller than those corresponding to simulations of the WT network (p&lt;0.01 for two-tailed z-test) (<xref ref-type="fig" rid="fig2">Figure 2B,ii</xref>). Furthermore, correlation matrices obtained from two experimental datasets – CCLE (n = 52), GSE 73160 (n = 63) – also implied the existence of these two ‘teams’, an observation that was strengthened by their value of J metric being significantly larger (p&lt;0.01 for two-tailed z-test) than that of 1000 random networks considered here (<xref ref-type="fig" rid="fig2">Figure 2B,ii</xref>).</p><p>Put together, this excellent agreement among Boolean and RACIPE simulations and experimental data through correlation matrix underscores that the steady states obtained via simulations can be mapped on specific biological phenotypes seen in experimental data and endorses the idea about two ‘teams’ of molecular players that may inhibit each other to enable these steady states.</p></sec><sec id="s2-3"><title>SCLC network topological signatures underlie the emergence of biological phenotypes</title><p>The remarkable agreement among Boolean and RACIPE simulations, and the endorsement of the correlation patterns seen in simulations with the experimental data, leads us to the hypothesis that the underlying network topology is fundamental to the existence of these distinct phenotypes. To test this hypothesis, we formulated a metric to quantify the topological influence of one node on another, named as influence matrix (Inf). A path between two nodes (A and B) in a network of length l is defined as a series of connected edges starting at node A and ending at node B. While the interaction matrix (M) only quantifies the effect of nodes on each other for a path length of one, the influence matrix considers path lengths of up to <inline-formula><mml:math id="inf1"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> to calculate this effect. Each element of the influence matrix, Inf<sub>ij</sub>, is a number between −1 and 1, calculated as a weighted sum of net effect of all paths of length less than <inline-formula><mml:math id="inf2"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> from ith node to jth node (see Materials and methods). Inf<sub>ij</sub> &gt; 0 indicates net activation, Inf<sub>ij</sub> &lt; 0 suggests net inhibition, and Inf<sub>ij</sub> = 0 implies no net effect.</p><p>The influence matrix for path length <inline-formula><mml:math id="inf3"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> = 10 obtained for the WT network was very similar to the corresponding correlation matrix for RACIPE (<xref ref-type="fig" rid="fig3">Figure 3A,i,</xref> <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) This similarity elucidates that the players in the two ‘teams’ are highly likely to effectively activate one another, but players belonging to different teams are likely to inhibit each other. To quantify this similarity, we calculated two metrics – R1 and R2 – bearing in mind that while the correlation matrix is symmetric, the influence matrix need not be. R1 is the correlation coefficient obtained from a scatter plot of regressing correlation coefficients between node i and j (P<sub>ij</sub>) and corresponding influence matrix element (Inf<sub>ij</sub>). R2 is defined the same as R1 but for Inf<sub>ji</sub> instead of Inf<sub>ij</sub>. Both R1 and R2 values are high (&gt;0.85) and statistically significant (<xref ref-type="fig" rid="fig3">Figure 3A,ii</xref>) and show a saturating trend for increasing path length (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), thus we chose <inline-formula><mml:math id="inf4"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> = 10 for further analysis from influence matrix. The high values of R1 and R2, together with high coefficient of determination (<xref ref-type="fig" rid="fig3">Figure 3A,ii</xref>), reinforce that the influence matrix of WT SCLC network is quite similar to corresponding correlation matrix. Similar trends seen for correlation matrix from CCLE endorsed that the influence matrix can not only capture the patterns for steady states, but also can reflect biological phenotypes seen in SCLC (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Topological features underlying the two ‘teams’ in SCLC network.</title><p>(<bold>A</bold>) (i) (Left) Pearson’s correlation matrix P for RACIPE simulations of WT SCLC network (P<sub>ij</sub> = P<sub>ji</sub>). (Right) Influence matrix Inf for WT SCLC network for path length = 10. Heatmap denotes P<sub>ij</sub> and Inf<sub>ij</sub> values, respectively. (ii) (left) Scatter plot for P<sub>ij</sub> and Inf<sub>ij</sub> values (for i &lt; j, i.e. values in upper triangle of Inf and P matrices); (right) scatter plot for P<sub>ji</sub> and Inf<sub>ji</sub> values (for i &gt; j, i.e., values in upper triangle of Inf and P matrices). R1 and R2 denote corresponding correlation coefficient values. Colorbar represents Kernel density estimate of points in the scatter plot. (<bold>B</bold>) (i) Volcano plot of all R1 and R2 metrics for RACIPE WT correlation matrix and random networks’ influence matrices. Inset shows histogram of R1 and R2 values for corresponding cases. Horizontal line for p=0.05. Arrows point to R1 and R2 values of WT SCLC network. (ii) Same as (i) but for correlation matrix from CCLE. (<bold>C</bold>) (i) Reduced model derived from influence matrix; red bars show inhibition, and green arrows show activation. (ii) Steady-state frequencies obtained from reduced model one and that of WT SCLC network (n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Influence matrix based on Boolean simulations for states with various frustration levels Influence matrix in <xref ref-type="fig" rid="fig3">Figure 3A,i</xref> is based on simulations from RACIPE.</title><p>Influence matrices based on Boolean simulation results were also derived. Instead of taking all steady-state solutions together, we classified them into three categories – states 1–4 in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref> (frustration value = 0.142), states 5–6 (frustration = 0.375), and states 7–10 (frustration = 0.383–0.386) – and derived corresponding influence matrices shown above. Labels 1–33 are the same as in <xref ref-type="fig" rid="fig2">Figure 2</xref>. The larger the frustration (or the smaller the frequency), the more the deviation of influence matrix from the correlation matrix shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Topological features.</title><p>(<bold>A</bold>) Scatter plot of R1 and R2 values obtained for varying path lengths, when influence matrix values/coefficients (for varying path lengths) for WT SCLC network were regressed against correlation coefficients from (i) RACIPE and (ii) CCLE. (<bold>B</bold>) (i) Scatter Plot of R1 and R2 values of influence coefficients of WT network and CCLE correlation coefficients for path length = 10. (<bold>C</bold>) (i) Reduced model derived from interaction matrix; red bars show inhibition, and green arrows show activation. (ii) Steady-state frequencies obtained from reduced model one and that of WT SCLC network (n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig3-figsupp2-v2.tif"/></fig></fig-group><p>Next, we checked the specificity of the influence matrix to the WT network. We next regressed the elements of RACIPE correlation matrix of WT SCLC network against corresponding elements for influence matrix of one of the 1000 random networks we had simulated using asynchronous Boolean model formalism. Thus, we calculated 1000 values of R1 and R2 for all the random networks; none of them were anywhere close to R1 and R2 of the WT SCLC network; many of these correlations were not even statistically significant (<xref ref-type="fig" rid="fig3">Figure 3B,i</xref>). Similar results were seen in the influence matrix from CCLE (<xref ref-type="fig" rid="fig3">Figure 3B,ii</xref>). Thus, we concluded that this influence matrix is unique to the WT SCLC network.</p><p>Put together, the influence matrix can be a more meaningful readout of interaction matrix in terms of effect of node <italic>i</italic> on node <italic>j</italic>. The influence matrix provides further credence to the idea that the SCLC network contains two ‘teams’ of players that are mutually inhibitory and self-activatory. To strengthen the concept of these two ‘teams’ of genes working together in a more qualitative sense, we constructed two reduced models from ‘effective’ edges calculated both from the interaction matrix and from the influence matrix (for path length = 10) (see Materials and methods) (<xref ref-type="fig" rid="fig3">Figure 3C,ii</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C,i</xref>). We performed asynchronous Boolean simulations for these reduced models using the Ising formalism. To compare the output of these reduced models with that of the WT SCLC network, we transformed the most frequent states of the WT SCLC network (shown in <xref ref-type="fig" rid="fig1">Figure 1B</xref>) into a representation using the same nodes as that included in the reduced networks. We observed that both reduced models – one generated from interaction matrix and another from influence matrix – resulted in the same four states as that of the WT (<xref ref-type="fig" rid="fig3">Figure 3C,ii</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C,ii</xref>). However, the network obtained using the influence matrix was closer to WT in terms of steady-state frequency distribution as compared to the one obtained using the interaction matrix. These results suggest that influence matrix is a better representation of network topology as compared to the interaction matrix.</p><p>Put together, we defined an influence matrix to decode the relative strengths of bidirectional regulatory interactions between every possible pair of nodes in the network. Analysis based on the influence matrix established the concept of two ‘teams’ of players that are effectively inhibiting each other and activating themselves, thereby forming an ‘effective’ self-activating toggle switch (SATS). Such SATS have been shown to be multistable and tend to underlie phenotypic plasticity and heterogeneity in multiple cell-fate decisions (<xref ref-type="bibr" rid="bib24">Guantes and Poyatos, 2008</xref>; <xref ref-type="bibr" rid="bib40">Lu et al., 2013</xref>; <xref ref-type="bibr" rid="bib55">Sahoo et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Zhou and Huang, 2011</xref>). This ‘teaming up’ can potentially explain (1) why single-edge perturbations in the WT SCLC network are rarely disruptive in terms of steady-state distributions (because as long as an ‘effective’ mutual inhibition between the two teams and ‘effective’ self-activation in the teams is maintained, the phenotypes are likely to be robust attractors) and (2) why despite such dense and complicated (33 nodes, 357 edges) network, we obtain only four steady states (because the ‘latent’ network topology is fundamentally simplistic).</p></sec><sec id="s2-4"><title>Classifying experimental SCLC data based on ASCL1 and NEUROD1</title><p>The first classification of SCLC was based on differences in cell morphology: a ‘classic’ type of cells that grow as spherical aggregates of floating cells and another relatively less prevalent ‘variant’ type which grew as tightly adherent monolayer or as loosely adherent aggregates. The ‘classic’ type had relatively higher levels of NE markers such as ASCL1 (<xref ref-type="bibr" rid="bib19">Gazdar et al., 1985</xref>). Next, SCLCs were categorized into two categories based on relative levels of ASCL1 and NEUROD1, both of which are key developmental nodes for pulmonary NE cells (<xref ref-type="bibr" rid="bib51">Poirier et al., 2013</xref>). Functional contributions of ASCL1 and/or NEUROD1 in SCLC have since been extensively explored (<xref ref-type="bibr" rid="bib8">Borromeo et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Ikematsu et al., 2020</xref>; <xref ref-type="bibr" rid="bib48">Osborne et al., 2013</xref>). Further characterization of SCLC proposed three different phenotypes – ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>, ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>, and a ‘double negative’ ASCL1<sup>low</sup>/NEUROD1<sup>low</sup> (<xref ref-type="bibr" rid="bib52">Poirier et al., 2015</xref>). In addition, a ‘double positive’ ASCL1<sup>high</sup>/NEUROD1<sup>high</sup> state of SCLC was recently identified (<xref ref-type="bibr" rid="bib4">Baine et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Simpson et al., 2020</xref>). In a recent classification (<xref ref-type="bibr" rid="bib54">Rudin et al., 2019</xref>), ASCL1<sup>high</sup>/NEUROD1<sup>low</sup> was labeled as SCLC-A subtype, ASCL1<sup>low</sup>/NEUROD1<sup>low</sup> was categorized as non-NE (and subcategorized to SCLC-P and SCLC-Y subtypes), and ASCL1<sup>low</sup> /NEUROD1<sup>high</sup> was marked as SCLC-N (also referred to as NE-V1 <xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>; <xref ref-type="fig" rid="fig4">Figure 4A,i</xref>). Besides, the NE-V2 subtype expressed ASCL1 and had relatively higher levels of NEUROD1 as that seen in ASCL1<sup>high</sup>/NEUROD1<sup>low</sup> subtype; thus, NE-V2 can be conjectured to be ASCL1<sup>high</sup> /NEUROD1<sup>high</sup>.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Classification of SCLC phenotypes based on ASCL1 and NEUROD1.</title><p>(<bold>A</bold>) (i) Summary of classification of SCLC subtypes in the existing literature (adapted from <xref ref-type="bibr" rid="bib54">Rudin et al., 2019</xref>). (ii) Density-based scatter plot for ASCL1 and NEUROD1 levels, as obtained via RACIPE modeling. (<bold>B</bold>) (i) Hierarchical clustering of CCLE samples using ASCL1 and NEUROD1. (ii) Scatter plot of normalized gene expression data for CCLE samples for NEUROD1 and ASCL1. Color coding in dendrogram and scatter plot are synonymous (i.e. refer to the same cluster). (<bold>C</bold>) (i) Average Silhouette width for different values of K for K-means clustering of CCLE samples for NEUROD1 and ASCL1. Error bars denote replicates of clustering attempts. (ii) Number of samples and ASCL1 and NEUROD1 expression values as seen in four clusters of CCLE samples obtained for K = 4.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Analysis for GSE73160 using ASCL1 and NEUROD1.</title><p>(<bold>A</bold>) (i) Hierarchical clustering of GSE73160 dataset across ASCL1 and NEUROD1. (ii) Scatter plot of normalized gene expression for NEUROD1 vs ASCL1 of GSE73160 dataset, labeled by n = 4 clusters obtained from the earlier dendrogram. (<bold>B</bold>) (i) Silhouette score analysis across ASCL1 and NEUROD1 for the GSE73160 dataset. (ii) Expression levels ASCL1 and NEUROD1 in four clusters obtained from the GSE73160 dataset by k-means clustering.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Gene expression of nodes involved in graph after clustering: Red bars indicate a node belonging to group A, and blue bar indicates belonging to group B.</title><p>ASCL1, NEUROD1, YAP1, and POU2F3 have different colors for better comparison (<bold>A</bold>) (i–iv) Hierarchical clustering of CCLE dataset across ASCL1 and NEUROD1, with individual panels depicting individual clusters: (i) A+/N−, (ii) A+/N+, (iii) A−/N+, (iv) A−/N−. and (<bold>B</bold>) (i–iv) K-means clustering of GSE73160 dataset ASCL1 and NEUROD1, with individual panels depicting individual clusters: (i) A+/N−, (ii) A+/N+, (iii) A−/N+, (iv) A−/N−.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Clustering efficiency of other node pairs.</title><p>(<bold>A</bold>) (i) Pie-chart depicting the frequency of cases for different optimal k-values, as identified by average silhouette score analysis, for all combinations of two nodes taken at a time (<sup>33</sup>C<sub>2</sub>). (ii) Histogram depicting the distribution of average silhouette scores for k = 4 clusters (red dotted line indicates silhouette score for ASCL1-NEUROD1 based clustering). (<bold>B</bold>) Top five gene pairs with maximum silhouette scores, for k = 4 as the optimal cluster value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig4-figsupp3-v2.tif"/></fig></fig-group><p>Intriguingly, our simulations (<xref ref-type="fig" rid="fig1">Figure 1A,ii</xref>) are able to capture all these four phenotypes – these were the four most dominant steady states that Boolean and RACIPE results converged to. Thus, we were able to classify the Boolean steady states into four phenotypes – A+N+, A+N-, A-N+, and A-N- (where A represents ASCL1, N represents NEUROD1) (<xref ref-type="fig" rid="fig4">Figure 4A,ii</xref>). Hierarchical clustering of experimental data – CCLE (<xref ref-type="fig" rid="fig4">Figure 4B,i</xref>) and GSE73160 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A,i</xref>) – using ASCL1 and NEUROD1 levels depict a clear segregation into four large groups at an early level. These four clusters were indeed A+N+, A+N-, A-N+, and A-N- (<xref ref-type="fig" rid="fig4">Figure 4B,ii</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, ii). Alternate clustering methods such as K-means revealed K = 4 as the optimal number of clusters, based on the average Silhouette width analysis (<xref ref-type="fig" rid="fig4">Figure 4C,i</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B,i</xref>), thus strengthening the results obtained from Boolean and RACIPE analysis. These four clusters obtained by K-means also split into A+N+, A+N-, A-N+, and A-N- (<xref ref-type="fig" rid="fig4">Figure 4C,ii</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>,ii) reminiscent of observations that a classification system employing only ASCL1 and NEUROD1 may be sufficient to describe these four biologically meaningful phenotypes (<xref ref-type="bibr" rid="bib8">Borromeo et al., 2016</xref>).</p><p>Based on the ‘groups’ we identified from influence matrix, ASCL1 was found to be a part of group A while NEUROD1 did not belong to any group (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Therefore, we examined whether the expression levels of genes in group A were high in samples identified as A+N- and A+N+. Indeed, in CCLE and GSE73160, we observed that A+N- and A+N+ subgroups had high levels of group A and low levels of group B; NEUROD1 did not show any group-specific pattern (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). This observation endorses that states identified by mechanistic modeling are recapitulated in vitro.</p><p>Given that our choice of using ASCL1 and NEUROD1 to cluster SCLC cell lines was based on experimental data, we conducted an unbiased analysis of using any 2 of 33 possible nodes for characterization (i.e. <sup>33</sup>C<sub>2</sub> = 528 combinations) in their ability to define four SCLC phenotypes. Only 140 such combinations yielded four as the optimal number of clustering, and the ASCL1-NEUROD1 pair showed up in the top 5 of the node pairs with maximal resolvability (measured via average Silhouette width) in defining these four phenotypes. Thus, the ASCL1 and NEUORD1 pair featured among the top 1% (in top 5 of 528 possibilities) of gene pairs in characterizing SCLC heterogeneity (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>).</p></sec><sec id="s2-5"><title>Extended subtype classification of SCLC into five phenotypes based on POU2F3 and YAP1</title><p>Besides ASCL1 and NEUROD1, YAP1 and POU2F3 have been reported as important regulators of SCLC, particularly for the non-NE phenotype (<xref ref-type="bibr" rid="bib4">Baine et al., 2020</xref>; <xref ref-type="bibr" rid="bib30">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Ito et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">McColl et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Song et al., 2020</xref>). Thus, we investigated the role of these players in defining SCLC phenotypes. We performed hierarchical clustering over the four genes of interest (ASCL1, NEUROD1, YAP1, POU2F3) on the CCLE dataset (<xref ref-type="fig" rid="fig5">Figure 5A,i</xref>) and GSE73160 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>, i). We observed five clusters, and when projected on the ASCL1-NEUROD1 axis, two of these five clusters were both present in the third quadrant (A-N-), suggesting that non-NE phenotype (ASCL1<sup>low</sup>/NEUROD1<sup>low</sup>) may be divided into two sub-clusters based on levels of YAP1 and POU2F3 (<xref ref-type="fig" rid="fig5">Figure 5A,ii</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,ii</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Classification of SCLC phenotypes based on ASCL1, NEUROD1, YAP1, and POU2F3.</title><p>(<bold>A</bold>) (i) Hierarchical clustering of CCLE samples using ASCL1, NEUROD1, YAP1, and POU2F3. (ii) Scatter plot of normalized gene expression data for CCLE samples for NEUROD1 and ASCL1. Color coding in dendrogram and scatter plot are synonymous (i.e. refer to the same cluster). (<bold>B</bold>) (i) Average levels of expression values for ASCL1, NEUROD1, YAP1, and POU2F3 for the four clusters identified in CCLE SCLC cell lines for K = 4. (ii) Same as (i) but for K = 5. (<bold>C</bold>) UMAP projections for CCLE dataset from four dimensions (ASCL1, NEUROD1, YAP1, and POU2F3) to two dimensions. Colorbar shows individual expression levels of ASCL1, NEUROD1, POU2F3, and YAP1. Color of the enclosing circle follows the same scheme as that for dendrogram and scatter plot.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis for GSE73160 using ASCL1, NEUROD1, POU2F3, and YAP1.</title><p>(<bold>A</bold>) (i) Hierarchical clustering of GSE73160 dataset across ASCL1, NEUROD1, YAP1, and NPOU2F3. (ii) Scatter plot of normalized gene expression for NEUROD1 vs ASCL1 of GSE73160 dataset, labeled by n = 5 clusters obtained from the earlier dendrogram. (<bold>B</bold>) (i) Expression levels of four classifying genes (ASCL1, NEUROD1, YAP1, and POU2F3) in clusters obtained from the k-means algorithm for k = 4 in the GSE73160 dataset. (ii) Same as (i) but for k = 5. (<bold>C</bold>) (i–iv) UMAP projection of GSE73160 dataset from four dimensions (ASCL1, NEUROD1, YAP1, and POU2F3) to two dimensions. The labeling is based on expression levels of ASCL1 (i), NEUROD1 (ii), POU2F3 (iii), and YAP1 (iv).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64522-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To decipher the five clusters better, we first performed K-means clustering for K = 4 for CCLE using the levels of ASCL1, NEUROD1, YAP1, and POU2F3 and observed the four clusters: SCLC-A1 (A+; n = 28), SCLC-N (N+; n = 12) and two non-NE phenotypes: SCLC-Y (Y+; n = 8) and SCLC-P (P+; n = 4) (<xref ref-type="fig" rid="fig5">Figure 5B,i</xref>). When K-means clustering for K = 5 was performed on the same dataset using the four above-mentioned genes, SCLC-Y (Y+; n = 8) and SCLC-P (P+; n = 4) had identical composition as the corresponding clusters for K = 4 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2a</xref>; <xref ref-type="fig" rid="fig5">Figure 5B,ii</xref>). Among 12 cell lines classified as SCLC-N (N+), 11 of them were still classified as SCLC-N with the exception of CORL279, which was classified as A+N+. Interestingly, the SCLC-A (A+; n = 28) cluster obtained for K = 4 broke into two sub-clusters: 14 cell lines were classified as ‘NE-V2’ (A+N+) and remaining 14 as SCLC-A. Similar trends were seen for hierarchical clustering, indicating the concurrence in assigning these different cell lines to SCLC phenotypes (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2a</xref>; <xref ref-type="fig" rid="fig5">Figure 5B,ii</xref>). This categorization suggests that the ‘double positive’ phenotype may be an intermediate one on the spectrum of ASCL1<sup>high</sup>/NEUROD1<sup>low</sup> (SCLC-A) to ASCL1<sup>low</sup>/NEUROD1<sup>high</sup> (SCLC-N) one, from the perspective of these four genes of interest. We compared the classification of the SCLC cell lines done using the levels of these four genes of interest with that done based on levels of a larger set of genes (<xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>) and obtained an overall good consistency, with a few (n = 5) exceptions where cell lines belonging to SCLC-A1 according to our clustering were found to belong to NEv2 as per the previous analysis (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2a</xref>). Performing the same procedure on another cohort of SCLC cell lines (GSE73160) – that showed consistent trends as for CCLE cohort (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>) – demonstrated that for K = 4 vs. K = 5, some SCLC-N cell lines were classified as the ‘double positive’ (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>), endorsing that cells may switch to this hybrid phenotype from SCLC-A1 and/or SCLC-N, similar to observations in hybrid E/M phenotypes (<xref ref-type="bibr" rid="bib71">Tripathi et al., 2020a</xref>).</p><p>Projecting the levels of these four genes of interest in SCLC cell lines on UMAP (Uniform Manifold Approximation and Projection) plots, we observed a neat splitting into five clusters – ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>/YAP1<sup>low</sup>/POU2F3<sup>low</sup>, ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>/YAP1<sup>low</sup>/POU2F3<sup>low</sup>, ASCL1<sup>high</sup>/NEUROD1<sup>high</sup>/YAP1<sup>low</sup>/POU2F3<sup>low </sup>– and two subtypes of ASCL1<sup>low</sup>/NEUROD1<sup>low</sup> – YAP1<sup>high</sup>/POU2F3<sup>low</sup> and YAP1<sup>low</sup>/POU2F3<sup>high</sup> (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Because UMAP does not require the number of clusters as an a priori input (as K-means clustering does), the emergence of these five clusters in this four-dimensional space is an independent validation of the robustness of these signatures based on the (relative) levels of ASCL1, NEUROD1, YAP1, and POU2F3. Put together, these results indicate that measuring the levels of these four molecules can be sufficient to quantify the degree of phenotypic heterogeneity, thereby corroborating our current status of understanding of functional relevance of these four key molecules in SCLC.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The focus on existence and dynamics of non-genetic, i.e., phenotypic, heterogeneity in cancer is a relatively recent one (<xref ref-type="bibr" rid="bib32">Inde and Dixon, 2018</xref>; <xref ref-type="bibr" rid="bib36">Jolly et al., 2018</xref>), given a reluctantly growing realization that extensive efforts and resources to map the genomic landscape solely has had limited success in decoding any fundamental organizing principles of cancer progression, especially metastasis (<xref ref-type="bibr" rid="bib10">Brock and Huang, 2017</xref>). While the existence of phenotypic heterogeneity in cancer cells is, by no means, a surprise, given its ubiquity in embryonic development (<xref ref-type="bibr" rid="bib28">Huang, 2009</xref>), the extent of our lack of understanding of organizing principles enabling it is appalling, relative to our current understanding of causes and consequences of phenotypic heterogeneity in ‘simpler’ biological organisms (<xref ref-type="bibr" rid="bib1">Ackermann, 2015</xref>; <xref ref-type="bibr" rid="bib75">van Boxtel et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Varahan et al., 2019</xref>).</p><p>Here, we demonstrate that the phenotypic heterogeneity in SCLC can emerge from multistable dynamics of underlying regulatory network. Multistability in this network has been reported based on Boolean (discrete, parameter-independent) simulations earlier (<xref ref-type="bibr" rid="bib72">Tripathi et al., 2020b</xref>; <xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>). Here, RACIPE – a continuous, parameter-agnostic approach – revealed that this multistability can be observed over many parametric combinations and reveal the predominance of the four states as seen in Boolean modeling, thereby elucidating the crucial role of network topology in facilitating multistability. These observations corroborate earlier work on comparative analysis of phenotypic (steady-state) distributions obtained from RACIPE and Boolean modeling for networks underlying epithelial–mesenchymal plasticity (EMP) (<xref ref-type="bibr" rid="bib26">Hari et al., 2020</xref>).</p><p>The four phenotypes in SCLC reported here – ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>, ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>, ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>, and ASCL1<sup>high</sup>/NEUROD1<sup>high</sup> – have been seen previously using varied Boolean modeling strategies and different networks (<xref ref-type="bibr" rid="bib72">Tripathi et al., 2020b</xref>; <xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>). Our focus is not to compare comprehensive gene expression profiles that have been mapped on to these phenotypes or to use statistical methods on transcriptomic data to infer modules of co-expressing genes, as has been extensively done before for SCLC. Rather, we use a complementary approach – RACIPE – to ascertain whether the phenotypes obtained via Boolean approaches are seen in ODE models also, and consequently identify design principles of the complex SCLC network, which constrain the number of steady states obtained. While RACIPE identifies many more steady states, this feature can be attributed to its continuous mode of simulation, a difference we also noted earlier in EMP networks (<xref ref-type="bibr" rid="bib26">Hari et al., 2020</xref>). The biological significance, if any, of these additional states needs further investigation. Furthermore, both Boolean and RACIPE approaches are implemented here only on transcriptional networks, whereas additional mechanisms such as epigenetics may alter frequency of steady states by effectively altering network topology (<xref ref-type="bibr" rid="bib64">Somarelli et al., 2016</xref>).</p><p>Moreover, here, we quantified the role of network topology by defining an influence matrix that revealed that the SCLC network consists of two ‘teams’ of players that mutually inhibit each other and self-activate themselves. This topological signature helps understand why despite such size, density, and complexity of the network, it led to a limited number of steady states. Interestingly, this property of the network was largely intact upon most single-edge perturbations, indicating enough redundancy and robustness in underlying network design. We found this property of the network is unique to this topology: not only was it lost upon randomization, but also none of the steady states obtained from random networks matched with that of the WT network topology. Importantly, we observed striking similarity between the influence matrix and the correlation matrix that included pairwise correlations among all gene expression values, endorsing that the influence matrix can provide an approximate readout of the patterns of steady states that can be expected in a network and that can be deciphered without having to simulate the dynamics of the network. However, the scalability or universality of influence matrix remains to be investigated cautiously.</p><p>Importantly, the patterns of steady states seen in influence and correlation matrices matched well with those seen in experimental data. This observation evoked confidence in biological insights that can be gained from the simulations of SCLC network. First, ASCL1 and NEUROD1, the two master regulators extensively reported in SCLC (<xref ref-type="bibr" rid="bib34">Jiang et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Osborne et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Poirier et al., 2013</xref>), did not lie in the same ‘team’, consistent with recent reports that they regulate distinct set of genes and that ASCL1<sup>high</sup> and NEUROD1<sup>high</sup> cell lines can have quite distinct chromatin landscapes too (<xref ref-type="bibr" rid="bib8">Borromeo et al., 2016</xref>). Second, clustering based results raised the possibility that some SCLC cell lines may represent a ASCL1<sup>high</sup>/NEUROD1<sup>high</sup> state, which can be perceived as an ‘intermediate’ state between the canonical SCLC-A (ASCL1<sup>high</sup>/NEUROD1<sup>low</sup>) and SCLC-N (ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>) ones. Similar ‘intermediate’ states are witnessed in diverse biological contexts (<xref ref-type="bibr" rid="bib15">Duddu et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Jolly et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Tripathi et al., 2020c</xref>; <xref ref-type="bibr" rid="bib82">Yu et al., 2017</xref>). Profiling of circulating tumor cell-derived explant models (CDXs) supports such possibility in SCLC (<xref ref-type="bibr" rid="bib63">Simpson et al., 2020</xref>). Third, multistability often leads to phenotypic switching and co-existence of multiple states (heterogeneity). Mouse models of SCLC reveal phenotypically distinct cells with a NE or non-NE marker profile that cooperated to enhance their metastatic potential (<xref ref-type="bibr" rid="bib12">Calbo et al., 2011</xref>), offering selective advantage to the tumor. Recent single-cell RNA-seq measurements of CDXs and patient-derived circulating tumor cells demonstrated intra-tumor heterogeneity (ITH). Particularly, ITH was found to be higher in drug-resistant CDXs relative to drug-sensitive ones and was found to have a transcriptional rather than a genomic basis (<xref ref-type="bibr" rid="bib67">Stewart et al., 2020</xref>). Thus, it is expected that most SCLC tumors contain cells in these phenotypes with varying frequencies, i.e., one SCLC tumor can contain multiple subtypes within it (<xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>), as has been postulated for breast cancer (<xref ref-type="bibr" rid="bib81">Yeo and Guan, 2017</xref>). Their relative frequency can be altered by adaptations at genetic and/or non-genetic levels (<xref ref-type="bibr" rid="bib46">Mollaoglu et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>).</p><p>A limitation of our simulations is the inability to account for the two ‘non-NE’ subtypes, SCLC-Y (YAP1<sup>high</sup>) and SCLC-P (POU2F3<sup>high</sup>), because the SCLC regulatory network simulated (<xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>) does not contain YAP1 or POU2F3 as nodes. Thus, we performed clustering using ASCL1, NEUROD1, YAP1, and POU2F3 for SCLC cell lines and observed YAP1 and POU2F3 expression to be largely mutually exclusive within the ‘double negative’ ASCL1<sup>low</sup>/NEUROD1<sup>low</sup> cluster. These results are consistent with recent analysis of SCLC cell lines (<xref ref-type="bibr" rid="bib33">Ito et al., 2016</xref>), CDXs (<xref ref-type="bibr" rid="bib49">Pearsall et al., 2020</xref>), and patient samples (<xref ref-type="bibr" rid="bib4">Baine et al., 2020</xref>). Furthermore, YAP1 negatively correlate with INSM1 (<xref ref-type="bibr" rid="bib42">McColl et al., 2017</xref>), a crucial regulator of NE differentiation in SCLC (<xref ref-type="bibr" rid="bib18">Fujino et al., 2015</xref>), which was found to be ‘ON’ in our A+N- and A+N+ states. Interestingly, A-N+ (ASCL1<sup>low</sup>/NEUROD1<sup>high</sup>) is classified as NE-variant (NEv1) (<xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>). Concomitantly, NEUROD1 has been associated with ‘mesenchymal’ (i.e., non-NE) markers (<xref ref-type="bibr" rid="bib63">Simpson et al., 2020</xref>) and features such as migration (<xref ref-type="bibr" rid="bib48">Osborne et al., 2013</xref>). Thus, in terms of an ‘NE score’, the phenotypes can be possibly expected to lie on a spectrum: ASCL1<sup>high</sup>/NEUROD1<sup>low </sup>≈ ASCL1<sup>high</sup>/NEUROD1<sup>high</sup> &gt; ASCL1<sup>low</sup>/NEUROD1<sup>high</sup> &gt; ASCL1<sup>low</sup>/NEUROD1<sup>low</sup>.</p><p>Our results highlight an important step in decoding the design principles of underlying regulatory network for phenotypic plasticity and heterogeneity in aggressive cancers such as SCLC. SCLC has no targeted therapy available till date (<xref ref-type="bibr" rid="bib69">Subbiah et al., 2020</xref>), a limitation that is expected to be overcome by recent surge in high-throughput experimental data collection for SCLC and computational approaches to identify SCLC subtypes for clinical action (<xref ref-type="bibr" rid="bib56">Salgia et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Stewart et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Tlemsani et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Udyavar et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>). An abysmal, if any, correlation between mutational profiles and distinct SCLC subtypes (<xref ref-type="bibr" rid="bib21">George et al., 2015</xref>), and multistability in SCLC network, argue for non-genetic causes of phenotypic heterogeneity. We have identified the topological signatures in underlying SCLC network that can give rise to multistability – two ‘teams’ of players with mutually inhibitory and self-activatory – and can result in a limited (n = 4) number of biologically relevant phenotypes, despite its overwhelming complexity (37 nodes, 357 edges). Such ‘motifs’ and consequent multistability appear to be the hallmarks of regulatory networks underlying cell differentiation and phenotypic plasticity (<xref ref-type="bibr" rid="bib11">Burda et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Shiraishi et al., 2010</xref>; <xref ref-type="bibr" rid="bib83">Zhou and Huang, 2011</xref>). Given that network topology can hold an impressive amount of information about both the steady-state and dynamical behaviors, as demonstrated for multiple gene regulatory networks (<xref ref-type="bibr" rid="bib2">Alon, 2007</xref>; <xref ref-type="bibr" rid="bib16">Feng et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Ma et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Santolini and Barabási, 2018</xref>; <xref ref-type="bibr" rid="bib22">Gómez Tejeda Zañudo et al., 2017</xref>), this work calls for an unprecedented approach to restrict the emergence of phenotypic heterogeneity in cancers – i.e., by ‘attacking’ (via tools such as CRISPR) the salient features of network topology.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Experimental data</title><p>Gene expression profiles of 52 SCLC cell lines were downloaded from Broad Institute’s CCLE expression data. Data for GSE73160 was downloaded from NCBI website.</p></sec><sec id="s4-2"><title>Normalization of experimental data</title><p>All data were normalized as per z-score normalization. The normalization was done across all the sample points (stable states or experimental data points) for a particular variable. The formula for calculating the z-score for jth observation for the ith variable is:<disp-formula id="equ3"><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mtext> </mml:mtext><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula>where μ is the mean, and σ is the standard deviation. For the purposes of the code, we used the <bold>preprocessing.scale</bold> function of the <bold>sklearn</bold> package in python.</p></sec><sec id="s4-3"><title>Correlation analysis</title><p>Pearson correlation co-efficient is a statistic that measures the linear correlation between two variables of interest. It depicts how strongly two variables are linearly related. It has a value between +1 and −1. A value of +1 is the total positive linear correlation, 0 is no linear correlation, and −1 is a total negative linear correlation. This static is applied to the experimental data to get the sense of how closely the expression levels of several nodes are linearly related. For the purposes of the code, the <bold>scipy.stats.pearsonr</bold> function of the <bold>scipy</bold> package in python was used. Along with the Pearson correlation coefficient, the function also returns <bold>two-tail p-value</bold>, which tells us whether two variables are statistically significant or not.</p></sec><sec id="s4-4"><title>Uniform Manifold Approximation and Projection</title><p>UMAP is a dimension reduction technique that can be used for visualization (similar to t-SNE) and is considered an improvement over previous dimension reduction techniques. UMAP was applied on z-score normalized data. For the purposes of the code, the <bold>UMAP.fit_transform</bold> function of the <bold>umap</bold> package in python was used. The <italic>n_neighbours</italic> parameter was set to 4 (after extensive trials over a broad range of values) and <italic>n_epochs</italic> set to 1000. The rest of the parameters was set to default.</p></sec><sec id="s4-5"><title>Hierarchical clustering</title><p>Hierarchical clustering was applied to the z-score normalized data. For purposes of code, the <bold>cluster.hierarchy.linkage</bold> function of the <bold>scipy</bold> package in python was used with the method set to <italic>ward</italic>. The dendrograms were plotted using the same, with the color grouping decided by setting the threshold values to desirable values.</p></sec><sec id="s4-6"><title>K-means clustering</title><p>K-means algorithm was applied to the z-score normalized data. For purposes of code, the <bold>cluster.KMeans</bold> function of the <bold>sklearn</bold> package in python was used with the <italic>init</italic> parameter set to <italic>random</italic>, the <italic>n_int</italic> set to 20, and <italic>max_iter</italic> to 300.</p></sec><sec id="s4-7"><title>Silhouette score analysis</title><p>Silhouette score is a way to determine the goodness of fit of a particular k-value in k-means clustering. It depicts how close the points in a cluster are to other points in the same cluster versus the other clusters. A higher score shows well-differentiated clustering. For the purposes of the code, we used <bold>metrics.silhouette_score</bold> function from the <bold>sklearn</bold> package in python, with the identified clusters being taken from <bold>fit_predict</bold> function applied to clusters obtained from the k-means algorithm outlined above.</p></sec><sec id="s4-8"><title>Influence matrix</title><p>The influence matrix is a formulation similar to that of the interaction matrix (<inline-formula><mml:math id="inf5"><mml:mrow><mml:mi>M</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula>), but gives a more comprehensive estimation of the effect of each on others in the network. For a given pair of nodes A and B, a path is a collection of serially connected edges originating from A and ending at B. The pathlength is then defined as the number of edges in such a path. Therefore, the interaction matrix depicts the influence of each node on the other for a pathlength of one. Consider the matrix <inline-formula><mml:math id="inf6"><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula>. The elements of the matrix can be written as:<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p>Which is the influence of ith node on the jth node when considering all paths of length 2. Similarly, each element of the matrix <inline-formula><mml:math id="inf7"><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></inline-formula> depicts the influence of nodes over pathlengths of <inline-formula><mml:math id="inf8"><mml:mi>l</mml:mi></mml:math></inline-formula>. We then calculate the influence matrix for a pathlength of <inline-formula><mml:math id="inf9"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> by combining the matrices <inline-formula><mml:math id="inf10"><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="inf11"><mml:mrow><mml:mi>l</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> as follows:<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo> </mml:mo><mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Σ</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:mi>l</mml:mi><mml:mo> </mml:mo><mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo> </mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mi>l</mml:mi></mml:msup><mml:mo>/</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow/><mml:mi>l</mml:mi></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p><inline-formula><mml:math id="inf12"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, obtained by setting all non-zero elements of the interaction matrix to 1, represents the magnitude of the maximum possible interaction for the given network topology and hence is used as the normalizing factor. The division (<inline-formula><mml:math id="inf13"><mml:mrow><mml:mfrac><mml:mi>M</mml:mi><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>) represents element-wise division and the range of the elements of the resultant matrix is restricted between −1 and 1. The summation is divided by <inline-formula><mml:math id="inf14"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> to again restrict the range of the elements between −1 and 1.</p></sec><sec id="s4-9"><title>Conversion from discrete to continuous formulation of correlation matrix</title><p>Experimental datasets gives us Pearson correlation coefficients which range from −1 to 1 (continuous values) while Boolean steady-state distribution (of both WT SCLC network and random networks) gives us correlation coefficients of either −1 or 1 (discrete values). Thus, we cannot formulate the J metric to be the same for all the cases. To make a fair comparison, we have converted the discrete values of the correlation coefficients to continuous values in the following way:</p><list list-type="bullet"><list-item><p>The Pearson correlation matrix of the steady-state distribution resulting from the Ising model is calculated (as mentioned in <bold>Correlation analysis</bold> section)</p></list-item> <list-item><p>The values of the correlation matrix are then replaced with a random number drawn from a uniform distribution (using the <bold>numpy.random.uniform</bold> from <bold>numpy</bold> package in Python 3.6) ranging between α and one for positive values and −1 and -α for negative values, where α = 0.01. The choice of α stems from the fact that all the correlation coefficients are statistically significant, p&lt;0.05. Therefore, the replacements must be statistically significant as well.</p></list-item> <list-item><p>For each Boolean network (WT SCLC network or Random network), 1000 such continuous correlation matrices are generated.</p></list-item> <list-item><p>J value is calculated for all the 1000 continuous correlation matrices obtained for a given network, and a mean of those 1000 values is taken as the J value for a given network.</p></list-item> <list-item><p>The value of J obtained for random networks (n = 1000) is plotted as a histogram.</p></list-item></list><p>Similar continuous formulation of correlation matrix was done for RACIPE correlation matrix as well, that is why the J value for RACIPE seen in <xref ref-type="fig" rid="fig2">Figure 2B,ii</xref> (J ~ 254) is smaller than that for RACIPE seen in <xref ref-type="fig" rid="fig2">Figure 2A,ii</xref> (J ~ 373), and similar to that for Boolean case as seen in <xref ref-type="fig" rid="fig2">Figure 2B,ii</xref> (J ~ 259).</p></sec><sec id="s4-10"><title>RACIPE and Boolean simulations</title><p>Please see details of Boolean and RACIPE simulations in Supplementary Information.</p></sec><sec id="s4-11"><title>Effective edge calculation and reduced networks</title><p>For a given Influence/Interaction matrix, an effective edge from a team of genes <inline-formula><mml:math id="inf15"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> to another team <inline-formula><mml:math id="inf16"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is given by the metric E:<disp-formula id="equ6"><mml:math id="m6"><mml:mrow><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mi>s</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>i</mml:mi><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>j</mml:mi><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>i</mml:mi><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>j</mml:mi><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="inf17"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf18"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> are teams of genes and <inline-formula><mml:math id="inf19"><mml:mi>i</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf20"><mml:mi>j</mml:mi></mml:math></inline-formula> are indices of genes in Influence matrix/Interaction matrix belonging to teams <inline-formula><mml:math id="inf21"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf22"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. Here <inline-formula><mml:math id="inf23"><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>, obtained by setting all non-zero elements of the influence matrix /interaction matrix to 1, represents the magnitude of the maximum possible interaction for the given network topology and hence is used as the normalizing factor.</p><p>Real numbers which are close to zero are taken to zero by defining a threshold by <inline-formula><mml:math id="inf24"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> given as.,<disp-formula id="equ7"><mml:math id="m7"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo> </mml:mo><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo> <mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&gt;</mml:mo><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0</mml:mn><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow> </mml:mrow></mml:mrow></mml:math></disp-formula></p><p>For the Reduced models, Threshold is taken as 0.05. Effective edges are reported using Signum function <inline-formula><mml:math id="inf25"><mml:mrow><mml:mi>s</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> which extracts the sign of real number given as:<disp-formula id="equ8"><mml:math id="m8"><mml:mrow><mml:mi>s</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo> </mml:mo><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo> <mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo> </mml:mo><mml:mi>x</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0</mml:mn><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo> </mml:mo><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo> </mml:mo><mml:mi>x</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow> </mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Using these edges, one can make reduced models from Influence matrix of any length and for a specific threshold.</p><p>To clearly understand how the two ‘teams’ of genes (group A: 22 genes – labeled from 1 to 22 in <xref ref-type="fig" rid="fig2">Figure 2</xref> and group B: 10 genes – labeled from 24 to 33 in <xref ref-type="fig" rid="fig2">Figure 2</xref>), subnetworks were generated consisting of genes from individual teams. NEUROD1 is not a part of either group because it did not show any correlation with either team per se in correlation matrix.</p><p>Another interesting observation in steady states observed in <xref ref-type="fig" rid="fig1">Figure 1B</xref> is that state 1 and state 4 (and similarly, state 2 and state 3) differ only in the levels of NEUROD1 (i.e. degeneracy in NEUROD1). Given the observations stated above, we expected the subnetworks to yield two states, all on and all off. Interestingly when genes of group A are simulated using the Ising model asynchronous update, we obtained four states as opposed to the expected two. Analysis of the states revealed that a degeneracy analogous to that of NEUROD1 in WT network was being caused by ELF3 in group A (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3a</xref>, S7). Therefore, we decided to include ELF3 as an independent entity for the reduced model. However, steady-state frequencies of group B did not reveal any such degeneracy caused due to ELF3 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3c</xref>, S9). By calculating the ‘effective edges’ metric described above, we observed two differences in the reduced model obtained from influence matrix (model 1; <xref ref-type="fig" rid="fig3">Figure 3C</xref>) and that obtained from interaction matrix (model 2; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2c</xref>). Model 1, but not model 2, contains self-activation on ELF3 as well as an activatory link from team A to ELF3.</p></sec><sec id="s4-12"><title>Single-edge perturbation</title><p>We perturbed each edge of WT SCLC network in the following two ways:</p><list list-type="order"><list-item><p>Change of sign of the edge (A → B to A ⊣ B and vice versa)</p></list-item> <list-item><p>Deletion of the edge (A → B/A ⊣ B to A ϕ B) where ϕ indicates the absence of a link. Every perturbed network is then simulated using the Ising model with asynchronous update for 2^20 random initial conditions. JSD is calculated for the resulting state distributions with respect to the steady-state distribution of WT SCLC network.</p></list-item></list></sec><sec id="s4-13"><title>Boolean framework – Ising model with asynchronous update</title><p> Ising model formalism uses discrete variables to represent the expression level of molecular species (such as micro-RNA or transcription factors etc.). Therefore, the state of the regulatory network (N-node network) can be represented by a sequence {<inline-formula><mml:math id="inf26"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="inf27"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>∈ {−1, 1}} called a ‘Boolean Vector’ of N binary variables where <inline-formula><mml:math id="inf28"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> = 1 represents high-expression level of <italic>i</italic>th node and <inline-formula><mml:math id="inf29"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> = −1 represents low expression of the node. In modeling the dynamics of network via this framework, the only knowledge required is whether each regulatory relationship between network nodes is activating or inhibitory. Regulatory interactions between the molecular species are represented by an N*N matrix called an ‘Interaction Matrix (M)’ where <inline-formula><mml:math id="inf30"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> = 1 represents ‘promotion’ (or activation) of levels of <italic>i</italic>th node by <italic>j</italic>th node and <inline-formula><mml:math id="inf31"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> = −1 represents ‘inhibition’ (or repression) of levels of <italic>i</italic>th node by <italic>j</italic>th node of the N-node network. The absence of any regulatory relationship between species <italic>i</italic> and species <italic>j</italic> is indicated by <inline-formula><mml:math id="inf32"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> = 0.</p><p>At every discrete-time step, the expression level of a node <inline-formula><mml:math id="inf33"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>(t+1) is given as +1 if <inline-formula><mml:math id="inf34"><mml:mrow><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> and −1 if <inline-formula><mml:math id="inf35"><mml:mrow><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> and remains the same when <inline-formula><mml:math id="inf36"><mml:mrow><mml:munderover><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo movablelimits="false">∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>. The expression levels are updated using the asynchronous scheme in which a node from the N-node network is picked up at random at every discrete-time step and updated using the above non-linear relation. For large discrete-time dynamics, the network settles in a steady state, which means that the Boolean Vector is a fixed point of the above-given relation (i.e. will not change as time progresses).</p></sec><sec id="s4-14"><title>RAndom CIrcuit PErturbation</title><p>RACIPE is a tool that identifies robust dynamical properties of transcriptional regulatory networks (TRNs) by generating an ensemble of continuous network models with distinct kinetic parameters. For every continuous model of a TRN, RACIPE first generates a system of ordinary differential equations (ODEs). For a given node ‘N’ of the TRN and a set of input activating edges <inline-formula><mml:math id="inf37"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and input inhibiting edges <inline-formula><mml:math id="inf38"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, the differential equation corresponding to the expression level of N is given as:</p><p>Here, <inline-formula><mml:math id="inf39"><mml:mrow><mml:mi>N</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="inf40"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> represent the expression levels of the species of the TRN. <inline-formula><mml:math id="inf41"><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf42"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> denote the Production and Degradation rates, respectively. <inline-formula><mml:math id="inf43"><mml:mrow><mml:msup><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:msub><mml:mrow/><mml:mrow><mml:mi>i</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the threshold value of <inline-formula><mml:math id="inf44"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> expression level at which the non-linearity in the dynamics of <inline-formula><mml:math id="inf45"><mml:mi>N</mml:mi></mml:math></inline-formula> due to <inline-formula><mml:math id="inf46"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is seen. <inline-formula><mml:math id="inf47"><mml:mi>n</mml:mi></mml:math></inline-formula> is termed as the Hill coefficient and represents the extent of non-linearity in the regulation. <inline-formula><mml:math id="inf48"><mml:mi>λ</mml:mi></mml:math></inline-formula> represents the fold change in the target node expression level upon over-expression of regulating nodes. The functions <inline-formula><mml:math id="inf49"><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf50"><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> are known as Shifted Hill functions (<xref ref-type="bibr" rid="bib40">Lu et al., 2013</xref>) and represent the regulation of the target node by the regulatory node. Shifted Hill functions take the following form:</p><p>For the system of ODEs, RACIPE randomly samples the kinetic parameters from a pre-defined set of parameter ranges. At each parameter set, RACIPE integrates the model from multiple initial conditions and obtains steady states in the state space. For the current analysis, a sample size of 10^6 for parameters sets and 1000 for initial conditions was used. The parameters were sampled via a uniform distribution, and the ODE integration was carried out using the Runge–Kutta–Fehlberg method of numerical integration.</p><p>For the given TRN with ‘n’ nodes, the steady-state expression levels of the nodes were normalized in the following way:</p><p>For the ith node, <inline-formula><mml:math id="inf51"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the normalized expression level of the node, <inline-formula><mml:math id="inf52"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the steady-state expression level, <inline-formula><mml:math id="inf53"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the normalization factor, <inline-formula><mml:math id="inf54"><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf55"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> are the production and degradation of the <italic>i</italic>th node corresponding the current steady-state, and <inline-formula><mml:math id="inf56"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are the fold change in the expression of node <italic>i</italic> due to node <italic>j</italic>. The normalized expression levels of all steady states are then converted into z-scores by scaling about their combined mean:</p><p>where <inline-formula><mml:math id="inf57"><mml:mrow><mml:munder accentunder="true"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>_</mml:mo></mml:munder></mml:mrow></mml:math></inline-formula> is the combined mean and <inline-formula><mml:math id="inf58"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo> </mml:mo></mml:mrow></mml:math></inline-formula> is the combined variance.</p><p>The z-scores can then be classified into Low (zero) and High (one) expression levels based on the sign of their values. This way we have discretized the continuous steady-state levels of the network for comparison with the frequency of Boolean steady states. The way to calculate the total frequency of each discrete state is by counting the occurrence in all the parameter sets. For parameter sets with n steady states, the count of each steady state is taken as 1/n, invoking the assumption that all the states are equally stable.</p></sec><sec id="s4-15"><title>Data and code availability</title><p>All codes are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/uday2607/CSB-SCLC">https://github.com/uday2607/CSB-SCLC</ext-link>; <xref ref-type="bibr" rid="bib14">Chauhan, 2021</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:223e7354cb6b32e82c56f62c130dbeaeda974412;origin=https://github.com/uday2607/CSB-SCLC;visit=swh:1:snp:19f287774066770688ea13dbb9521b7b757c33c2;anchor=swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e/">swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e</ext-link>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by Ramanujan Fellowship awarded to MKJ by Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India (SB/S2/RJN-049/2018).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Frequency distributions for SCLC network.</title><p>(a) Frequency distribution for asynchronous Boolean update of WT SCLC network using Ising update with 2<sup>20</sup> and 2<sup>25</sup> initial conditions over three replicates. (b) Steady-state frequency distribution for top 20 states of binarized RACIPE simulation of the network. (c) Node summary of single-edge perturbation of wild-type SCLC network.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64522-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Cell line classification using ASCL1, NEUROD1, YAP1 and POU2F3.</title><p>(a) Cell line classification of CCLE dataset using different cluster values for k-means and hierarchical algorithm over four genes of interest (ASCL1, NEUROD1, YAP1, and POU2F3). Also contains the classification as given by <xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref>. (b) Cell line classification of GSE73160 dataset using different cluster values for k-means and hierarchical algorithm over four genes of interest (ASCL1, NEUROD1, YAP1, and POU2F3). Also contains the classification as given by <xref ref-type="bibr" rid="bib79">Wooten et al., 2019</xref> (for the cell lines included in both GSE73160 and CCLE).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64522-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Frequency distributions for reduced SCLC network.</title><p>(a) Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP A and ELF3. (b) Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP A only. (c) Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP B only. (b) Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP A only. Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP B only. Steady-state frequency distribution for asynchronous Boolean update of network for genes corresponding to GROUP B and ELF3.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64522-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-64522-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Gene expression profiles of 52 SCLC cell lines were downloaded from Broad Institute's CCLE expression data. Data for GSE73160 was downloaded from NCBI website. All codes used to generate and analyze simulation data, and codes used to analyze gene expression data are available at : <ext-link ext-link-type="uri" xlink:href="https://github.com/uday2607/CSB-SCLC">https://github.com/uday2607/CSB-SCLC</ext-link> copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e/">https://archive.softwareheritage.org/swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e/</ext-link>.</p><p>The following previously published dataset was used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Polley</surname><given-names>E</given-names></name><name><surname>Kunkel</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>D</given-names></name><name><surname>Silvers</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Exon expression for NCI small cell lung cancer cell line panel</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73160">GSE73160</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A functional perspective on phenotypic heterogeneity in microorganisms</article-title><source>Nature Reviews Microbiology</source><volume>13</volume><fpage>497</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3491</pub-id><pub-id pub-id-type="pmid">26145732</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alon</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Network motifs: theory and experimental approaches</article-title><source>Nature Reviews Genetics</source><volume>8</volume><fpage>450</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1038/nrg2102</pub-id><pub-id pub-id-type="pmid">17510665</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armbruster</surname> <given-names>CR</given-names></name><name><surname>Lee</surname> <given-names>CK</given-names></name><name><surname>Parker-Gilham</surname> <given-names>J</given-names></name><name><surname>de Anda</surname> <given-names>J</given-names></name><name><surname>Xia</surname> <given-names>A</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Murakami</surname> <given-names>K</given-names></name><name><surname>Tseng</surname> <given-names>BS</given-names></name><name><surname>Hoffman</surname> <given-names>LR</given-names></name><name><surname>Jin</surname> <given-names>F</given-names></name><name><surname>Harwood</surname> <given-names>CS</given-names></name><name><surname>Wong</surname> <given-names>GCL</given-names></name><name><surname>Parsek</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heterogeneity in surface sensing suggests a division of labor in <italic>Pseudomonas aeruginosa</italic> populations</article-title><source>eLife</source><volume>8</volume><elocation-id>e45084</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45084</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baine</surname> <given-names>MK</given-names></name><name><surname>Hsieh</surname> <given-names>MS</given-names></name><name><surname>Lai</surname> <given-names>WV</given-names></name><name><surname>Egger</surname> <given-names>JV</given-names></name><name><surname>Jungbluth</surname> <given-names>AA</given-names></name><name><surname>Daneshbod</surname> <given-names>Y</given-names></name><name><surname>Beras</surname> <given-names>A</given-names></name><name><surname>Spencer</surname> <given-names>R</given-names></name><name><surname>Lopardo</surname> <given-names>J</given-names></name><name><surname>Bodd</surname> <given-names>F</given-names></name><name><surname>Montecalvo</surname> <given-names>J</given-names></name><name><surname>Sauter</surname> <given-names>JL</given-names></name><name><surname>Chang</surname> <given-names>JC</given-names></name><name><surname>Buonocore</surname> <given-names>DJ</given-names></name><name><surname>Travis</surname> <given-names>WD</given-names></name><name><surname>Sen</surname> <given-names>T</given-names></name><name><surname>Poirier</surname> <given-names>JT</given-names></name><name><surname>Rudin</surname> <given-names>CM</given-names></name><name><surname>Rekhtman</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization</article-title><source>Journal of Thoracic Oncology</source><volume>15</volume><fpage>1823</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2020.09.009</pub-id><pub-id pub-id-type="pmid">33011388</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname> <given-names>NQ</given-names></name><name><surname>Merrin</surname> <given-names>J</given-names></name><name><surname>Chait</surname> <given-names>R</given-names></name><name><surname>Kowalik</surname> <given-names>L</given-names></name><name><surname>Leibler</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bacterial persistence as a phenotypic switch</article-title><source>Science</source><volume>305</volume><fpage>1622</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1126/science.1099390</pub-id><pub-id pub-id-type="pmid">15308767</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Jacob</surname> <given-names>E</given-names></name><name><surname>Coffey</surname> <given-names>DS</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bacterial survival strategies suggest rethinking Cancer cooperativity</article-title><source>Trends in Microbiology</source><volume>20</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2012.06.001</pub-id><pub-id pub-id-type="pmid">22750098</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bódi</surname> <given-names>Z</given-names></name><name><surname>Farkas</surname> <given-names>Z</given-names></name><name><surname>Nevozhay</surname> <given-names>D</given-names></name><name><surname>Kalapis</surname> <given-names>D</given-names></name><name><surname>Lázár</surname> <given-names>V</given-names></name><name><surname>Csörgő</surname> <given-names>B</given-names></name><name><surname>Nyerges</surname> <given-names>Á</given-names></name><name><surname>Szamecz</surname> <given-names>B</given-names></name><name><surname>Fekete</surname> <given-names>G</given-names></name><name><surname>Papp</surname> <given-names>B</given-names></name><name><surname>Araújo</surname> <given-names>H</given-names></name><name><surname>Oliveira</surname> <given-names>JL</given-names></name><name><surname>Moura</surname> <given-names>G</given-names></name><name><surname>Santos</surname> <given-names>MAS</given-names></name><name><surname>Székely</surname> <given-names>T</given-names></name><name><surname>Balázsi</surname> <given-names>G</given-names></name><name><surname>Pál</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phenotypic heterogeneity promotes adaptive evolution</article-title><source>PLOS Biology</source><volume>15</volume><elocation-id>e2000644</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2000644</pub-id><pub-id pub-id-type="pmid">28632738</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borromeo</surname> <given-names>MD</given-names></name><name><surname>Savage</surname> <given-names>TK</given-names></name><name><surname>Kollipara</surname> <given-names>RK</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Augustyn</surname> <given-names>A</given-names></name><name><surname>Osborne</surname> <given-names>JK</given-names></name><name><surname>Girard</surname> <given-names>L</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name><name><surname>Gazdar</surname> <given-names>AF</given-names></name><name><surname>Cobb</surname> <given-names>MH</given-names></name><name><surname>Johnson</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs</article-title><source>Cell Reports</source><volume>16</volume><fpage>1259</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.06.081</pub-id><pub-id pub-id-type="pmid">27452466</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brock</surname> <given-names>A</given-names></name><name><surname>Chang</surname> <given-names>H</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours</article-title><source>Nature Reviews Genetics</source><volume>10</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nrg2556</pub-id><pub-id pub-id-type="pmid">19337290</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brock</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Precision oncology: between vaguely right and precisely wrong</article-title><source>Cancer Research</source><volume>77</volume><fpage>6473</fpage><lpage>6479</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0448</pub-id><pub-id pub-id-type="pmid">29162615</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burda</surname> <given-names>Z</given-names></name><name><surname>Krzywicki</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>OC</given-names></name><name><surname>Zagorski</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Motifs emerge from function in model gene regulatory networks</article-title><source>PNAS</source><volume>108</volume><fpage>17263</fpage><lpage>17268</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109435108</pub-id><pub-id pub-id-type="pmid">21960444</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calbo</surname> <given-names>J</given-names></name><name><surname>van Montfort</surname> <given-names>E</given-names></name><name><surname>Proost</surname> <given-names>N</given-names></name><name><surname>van Drunen</surname> <given-names>E</given-names></name><name><surname>Beverloo</surname> <given-names>HB</given-names></name><name><surname>Meuwissen</surname> <given-names>R</given-names></name><name><surname>Berns</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A functional role for tumor cell heterogeneity in a mouse model of small cell lung Cancer</article-title><source>Cancer Cell</source><volume>19</volume><fpage>244</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2010.12.021</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celià-Terrassa</surname> <given-names>T</given-names></name><name><surname>Kang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinctive properties of metastasis-initiating cells</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>892</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1101/gad.277681.116</pub-id><pub-id pub-id-type="pmid">27083997</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="software"><person-group person-group-type="author"> <name><surname>Chauhan</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>CSB-SCLC</data-title><source>Software Heritage</source><version designator="swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e">swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:223e7354cb6b32e82c56f62c130dbeaeda974412;origin=https://github.com/uday2607/CSB-SCLC;visit=swh:1:snp:19f287774066770688ea13dbb9521b7b757c33c2;anchor=swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e/">https://archive.softwareheritage.org/swh:1:dir:223e7354cb6b32e82c56f62c130dbeaeda974412;origin=https://github.com/uday2607/CSB-SCLC;visit=swh:1:snp:19f287774066770688ea13dbb9521b7b757c33c2;anchor=swh:1:rev:eb4c869fe572bb0a98a6a7ce7a09631ad584200e/</ext-link></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duddu</surname> <given-names>AS</given-names></name><name><surname>Sahoo</surname> <given-names>S</given-names></name><name><surname>Hati</surname> <given-names>S</given-names></name><name><surname>Jhunjhunwala</surname> <given-names>S</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multi-stability in cellular differentiation enabled by a network of three mutually repressing master regulators</article-title><source>Journal of the Royal Society Interface</source><volume>17</volume><elocation-id>20200631</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2020.0631</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>S</given-names></name><name><surname>Sáez</surname> <given-names>M</given-names></name><name><surname>Wiuf</surname> <given-names>C</given-names></name><name><surname>Feliu</surname> <given-names>E</given-names></name><name><surname>Soyer</surname> <given-names>OS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Core signalling motif displaying multistability through multi-state enzymes</article-title><source>Journal of the Royal Society Interface</source><volume>13</volume><elocation-id>20160524</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2016.0524</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Font-Clos</surname> <given-names>F</given-names></name><name><surname>Zapperi</surname> <given-names>S</given-names></name><name><surname>La Porta</surname> <given-names>CAM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Topography of epithelial–mesenchymal plasticity</article-title><source>PNAS</source><volume>115</volume><fpage>5902</fpage><lpage>5907</lpage><pub-id pub-id-type="doi">10.1073/pnas.1722609115</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujino</surname> <given-names>K</given-names></name><name><surname>Motooka</surname> <given-names>Y</given-names></name><name><surname>Hassan</surname> <given-names>WA</given-names></name><name><surname>Ali Abdalla</surname> <given-names>MO</given-names></name><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Kudoh</surname> <given-names>S</given-names></name><name><surname>Hasegawa</surname> <given-names>K</given-names></name><name><surname>Niimori-Kita</surname> <given-names>K</given-names></name><name><surname>Kobayashi</surname> <given-names>H</given-names></name><name><surname>Kubota</surname> <given-names>I</given-names></name><name><surname>Wakimoto</surname> <given-names>J</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Ito</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Insulinoma-Associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung Cancer</article-title><source>The American Journal of Pathology</source><volume>185</volume><fpage>3164</fpage><lpage>3177</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.08.018</pub-id><pub-id pub-id-type="pmid">26482608</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazdar</surname> <given-names>AF</given-names></name><name><surname>Carney</surname> <given-names>DN</given-names></name><name><surname>Nau</surname> <given-names>MM</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Characterization of variant subclasses of cell lines derived from small cell lung Cancer having distinctive biochemical, morphological, and growth properties</article-title><source>Cancer Research</source><volume>45</volume><fpage>2924</fpage><lpage>2930</lpage><pub-id pub-id-type="pmid">2985258</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazdar</surname> <given-names>AF</given-names></name><name><surname>Bunn</surname> <given-names>PA</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Small-cell lung Cancer: what we know, what we need to know and the path forward</article-title><source>Nature Reviews Cancer</source><volume>17</volume><fpage>725</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1038/nrc.2017.87</pub-id><pub-id pub-id-type="pmid">29077690</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname> <given-names>J</given-names></name><name><surname>Lim</surname> <given-names>JS</given-names></name><name><surname>Jang</surname> <given-names>SJ</given-names></name><name><surname>Cun</surname> <given-names>Y</given-names></name><name><surname>Ozretić</surname> <given-names>L</given-names></name><name><surname>Kong</surname> <given-names>G</given-names></name><name><surname>Leenders</surname> <given-names>F</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Fernández-Cuesta</surname> <given-names>L</given-names></name><name><surname>Bosco</surname> <given-names>G</given-names></name><name><surname>Müller</surname> <given-names>C</given-names></name><name><surname>Dahmen</surname> <given-names>I</given-names></name><name><surname>Jahchan</surname> <given-names>NS</given-names></name><name><surname>Park</surname> <given-names>KS</given-names></name><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Karnezis</surname> <given-names>AN</given-names></name><name><surname>Vaka</surname> <given-names>D</given-names></name><name><surname>Torres</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>MS</given-names></name><name><surname>Korbel</surname> <given-names>JO</given-names></name><name><surname>Menon</surname> <given-names>R</given-names></name><name><surname>Chun</surname> <given-names>SM</given-names></name><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Wilkerson</surname> <given-names>M</given-names></name><name><surname>Hayes</surname> <given-names>N</given-names></name><name><surname>Engelmann</surname> <given-names>D</given-names></name><name><surname>Pützer</surname> <given-names>B</given-names></name><name><surname>Bos</surname> <given-names>M</given-names></name><name><surname>Michels</surname> <given-names>S</given-names></name><name><surname>Vlasic</surname> <given-names>I</given-names></name><name><surname>Seidel</surname> <given-names>D</given-names></name><name><surname>Pinther</surname> <given-names>B</given-names></name><name><surname>Schaub</surname> <given-names>P</given-names></name><name><surname>Becker</surname> <given-names>C</given-names></name><name><surname>Altmüller</surname> <given-names>J</given-names></name><name><surname>Yokota</surname> <given-names>J</given-names></name><name><surname>Kohno</surname> <given-names>T</given-names></name><name><surname>Iwakawa</surname> <given-names>R</given-names></name><name><surname>Tsuta</surname> <given-names>K</given-names></name><name><surname>Noguchi</surname> <given-names>M</given-names></name><name><surname>Muley</surname> <given-names>T</given-names></name><name><surname>Hoffmann</surname> <given-names>H</given-names></name><name><surname>Schnabel</surname> <given-names>PA</given-names></name><name><surname>Petersen</surname> <given-names>I</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Soltermann</surname> <given-names>A</given-names></name><name><surname>Tischler</surname> <given-names>V</given-names></name><name><surname>Choi</surname> <given-names>CM</given-names></name><name><surname>Kim</surname> <given-names>YH</given-names></name><name><surname>Massion</surname> <given-names>PP</given-names></name><name><surname>Zou</surname> <given-names>Y</given-names></name><name><surname>Jovanovic</surname> <given-names>D</given-names></name><name><surname>Kontic</surname> <given-names>M</given-names></name><name><surname>Wright</surname> <given-names>GM</given-names></name><name><surname>Russell</surname> <given-names>PA</given-names></name><name><surname>Solomon</surname> <given-names>B</given-names></name><name><surname>Koch</surname> <given-names>I</given-names></name><name><surname>Lindner</surname> <given-names>M</given-names></name><name><surname>Muscarella</surname> <given-names>LA</given-names></name><name><surname>la Torre</surname> <given-names>A</given-names></name><name><surname>Field</surname> <given-names>JK</given-names></name><name><surname>Jakopovic</surname> <given-names>M</given-names></name><name><surname>Knezevic</surname> <given-names>J</given-names></name><name><surname>Castaños-Vélez</surname> <given-names>E</given-names></name><name><surname>Roz</surname> <given-names>L</given-names></name><name><surname>Pastorino</surname> <given-names>U</given-names></name><name><surname>Brustugun</surname> <given-names>OT</given-names></name><name><surname>Lund-Iversen</surname> <given-names>M</given-names></name><name><surname>Thunnissen</surname> <given-names>E</given-names></name><name><surname>Köhler</surname> <given-names>J</given-names></name><name><surname>Schuler</surname> <given-names>M</given-names></name><name><surname>Botling</surname> <given-names>J</given-names></name><name><surname>Sandelin</surname> <given-names>M</given-names></name><name><surname>Sanchez-Cespedes</surname> <given-names>M</given-names></name><name><surname>Salvesen</surname> <given-names>HB</given-names></name><name><surname>Achter</surname> <given-names>V</given-names></name><name><surname>Lang</surname> <given-names>U</given-names></name><name><surname>Bogus</surname> <given-names>M</given-names></name><name><surname>Schneider</surname> <given-names>PM</given-names></name><name><surname>Zander</surname> <given-names>T</given-names></name><name><surname>Ansén</surname> <given-names>S</given-names></name><name><surname>Hallek</surname> <given-names>M</given-names></name><name><surname>Wolf</surname> <given-names>J</given-names></name><name><surname>Vingron</surname> <given-names>M</given-names></name><name><surname>Yatabe</surname> <given-names>Y</given-names></name><name><surname>Travis</surname> <given-names>WD</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Reinhardt</surname> <given-names>C</given-names></name><name><surname>Perner</surname> <given-names>S</given-names></name><name><surname>Heukamp</surname> <given-names>L</given-names></name><name><surname>Büttner</surname> <given-names>R</given-names></name><name><surname>Haas</surname> <given-names>SA</given-names></name><name><surname>Brambilla</surname> <given-names>E</given-names></name><name><surname>Peifer</surname> <given-names>M</given-names></name><name><surname>Sage</surname> <given-names>J</given-names></name><name><surname>Thomas</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Comprehensive genomic profiles of small cell lung Cancer</article-title><source>Nature</source><volume>524</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nature14664</pub-id><pub-id pub-id-type="pmid">26168399</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez Tejeda Zañudo</surname> <given-names>J</given-names></name><name><surname>Scaltriti</surname> <given-names>M</given-names></name><name><surname>Albert</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast Cancer</article-title><source>Cancer Convergence</source><volume>1</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1186/s41236-017-0007-6</pub-id><pub-id pub-id-type="pmid">29623959</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grote</surname> <given-names>J</given-names></name><name><surname>Krysciak</surname> <given-names>D</given-names></name><name><surname>Streit</surname> <given-names>WR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phenotypic heterogeneity, a phenomenon that may explain why quorum sensing does not always result in truly homogenous cell behavior</article-title><source>Applied and Environmental Microbiology</source><volume>81</volume><fpage>5280</fpage><lpage>5289</lpage><pub-id pub-id-type="doi">10.1128/AEM.00900-15</pub-id><pub-id pub-id-type="pmid">26025903</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guantes</surname> <given-names>R</given-names></name><name><surname>Poyatos</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Multistable decision switches for flexible control of epigenetic differentiation</article-title><source>PLOS Computational Biology</source><volume>4</volume><elocation-id>e1000235</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000235</pub-id><pub-id pub-id-type="pmid">19043543</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname> <given-names>D</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hallmarks of Cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hari</surname> <given-names>K</given-names></name><name><surname>Sabuwala</surname> <given-names>B</given-names></name><name><surname>Subramani</surname> <given-names>BV</given-names></name><name><surname>La Porta</surname> <given-names>CAM</given-names></name><name><surname>Zapperi</surname> <given-names>S</given-names></name><name><surname>Font-Clos</surname> <given-names>F</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identifying inhibitors of epithelial-mesenchymal plasticity using a network topology-based approach</article-title><source>Npj Systems Biology and Applications</source><volume>6</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1038/s41540-020-0132-1</pub-id><pub-id pub-id-type="pmid">32424264</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Artibani</surname> <given-names>M</given-names></name><name><surname>Alsaadi</surname> <given-names>A</given-names></name><name><surname>Wietek</surname> <given-names>N</given-names></name><name><surname>Morotti</surname> <given-names>M</given-names></name><name><surname>Shi</surname> <given-names>T</given-names></name><name><surname>Zhong</surname> <given-names>Z</given-names></name><name><surname>Santana Gonzalez</surname> <given-names>L</given-names></name><name><surname>El-Sahhar</surname> <given-names>S</given-names></name><name><surname>KaramiNejadRanjbar</surname> <given-names>M</given-names></name><name><surname>Mallett</surname> <given-names>G</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Masuda</surname> <given-names>K</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Chong</surname> <given-names>K</given-names></name><name><surname>Damato</surname> <given-names>S</given-names></name><name><surname>Dhar</surname> <given-names>S</given-names></name><name><surname>Campo</surname> <given-names>L</given-names></name><name><surname>Garruto Campanile</surname> <given-names>R</given-names></name><name><surname>Soleymani Majd</surname> <given-names>H</given-names></name><name><surname>Rai</surname> <given-names>V</given-names></name><name><surname>Maldonado-Perez</surname> <given-names>D</given-names></name><name><surname>Jones</surname> <given-names>S</given-names></name><name><surname>Cerundolo</surname> <given-names>V</given-names></name><name><surname>Sauka-Spengler</surname> <given-names>T</given-names></name><name><surname>Yau</surname> <given-names>C</given-names></name><name><surname>Ahmed</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The repertoire of serous ovarian Cancer Non-genetic heterogeneity revealed by Single-Cell sequencing of normal fallopian tube epithelial cells</article-title><source>Cancer Cell</source><volume>37</volume><fpage>226</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2020.01.003</pub-id><pub-id pub-id-type="pmid">32049047</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Non-genetic heterogeneity of cells in development: more than just noise</article-title><source>Development</source><volume>136</volume><fpage>3853</fpage><lpage>3862</lpage><pub-id pub-id-type="doi">10.1242/dev.035139</pub-id><pub-id pub-id-type="pmid">19906852</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Jia</surname> <given-names>D</given-names></name><name><surname>Ben-Jacob</surname> <given-names>E</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name><name><surname>Onuchic</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interrogating the topological robustness of gene regulatory circuits by randomization</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005456</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005456</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>YH</given-names></name><name><surname>Klingbeil</surname> <given-names>O</given-names></name><name><surname>He</surname> <given-names>XY</given-names></name><name><surname>Wu</surname> <given-names>XS</given-names></name><name><surname>Arun</surname> <given-names>G</given-names></name><name><surname>Lu</surname> <given-names>B</given-names></name><name><surname>Somerville</surname> <given-names>TDD</given-names></name><name><surname>Milazzo</surname> <given-names>JP</given-names></name><name><surname>Wilkinson</surname> <given-names>JE</given-names></name><name><surname>Demerdash</surname> <given-names>OE</given-names></name><name><surname>Spector</surname> <given-names>DL</given-names></name><name><surname>Egeblad</surname> <given-names>M</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Vakoc</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>POU2F3 is a master regulator of a tuft cell-like variant of small cell lung Cancer</article-title><source>Genes &amp; Development</source><volume>32</volume><fpage>915</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1101/gad.314815.118</pub-id><pub-id pub-id-type="pmid">29945888</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikematsu</surname> <given-names>Y</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Toyokawa</surname> <given-names>G</given-names></name><name><surname>Ijichi</surname> <given-names>K</given-names></name><name><surname>Ando</surname> <given-names>N</given-names></name><name><surname>Yoneshima</surname> <given-names>Y</given-names></name><name><surname>Iwama</surname> <given-names>E</given-names></name><name><surname>Inoue</surname> <given-names>H</given-names></name><name><surname>Tagawa</surname> <given-names>T</given-names></name><name><surname>Nakanishi</surname> <given-names>Y</given-names></name><name><surname>Okamoto</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NEUROD1 is highly expressed in extensive-disease small cell lung Cancer and promotes tumor cell migration</article-title><source>Lung Cancer</source><volume>146</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.lungcan.2020.05.012</pub-id><pub-id pub-id-type="pmid">32526603</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inde</surname> <given-names>Z</given-names></name><name><surname>Dixon</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The impact of non-genetic heterogeneity on Cancer cell death</article-title><source>Critical Reviews in Biochemistry and Molecular Biology</source><volume>53</volume><fpage>99</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1080/10409238.2017.1412395</pub-id><pub-id pub-id-type="pmid">29250983</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>T</given-names></name><name><surname>Matsubara</surname> <given-names>D</given-names></name><name><surname>Tanaka</surname> <given-names>I</given-names></name><name><surname>Makiya</surname> <given-names>K</given-names></name><name><surname>Tanei</surname> <given-names>ZI</given-names></name><name><surname>Kumagai</surname> <given-names>Y</given-names></name><name><surname>Shiu</surname> <given-names>SJ</given-names></name><name><surname>Nakaoka</surname> <given-names>HJ</given-names></name><name><surname>Ishikawa</surname> <given-names>S</given-names></name><name><surname>Isagawa</surname> <given-names>T</given-names></name><name><surname>Morikawa</surname> <given-names>T</given-names></name><name><surname>Shinozaki-Ushiku</surname> <given-names>A</given-names></name><name><surname>Goto</surname> <given-names>Y</given-names></name><name><surname>Nakano</surname> <given-names>T</given-names></name><name><surname>Tsuchiya</surname> <given-names>T</given-names></name><name><surname>Tsubochi</surname> <given-names>H</given-names></name><name><surname>Komura</surname> <given-names>D</given-names></name><name><surname>Aburatani</surname> <given-names>H</given-names></name><name><surname>Dobashi</surname> <given-names>Y</given-names></name><name><surname>Nakajima</surname> <given-names>J</given-names></name><name><surname>Endo</surname> <given-names>S</given-names></name><name><surname>Fukayama</surname> <given-names>M</given-names></name><name><surname>Sekido</surname> <given-names>Y</given-names></name><name><surname>Niki</surname> <given-names>T</given-names></name><name><surname>Murakami</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of YAP1 defines neuroendocrine differentiation of lung tumors</article-title><source>Cancer Science</source><volume>107</volume><fpage>1537</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1111/cas.13013</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>T</given-names></name><name><surname>Collins</surname> <given-names>BJ</given-names></name><name><surname>Jin</surname> <given-names>N</given-names></name><name><surname>Watkins</surname> <given-names>DN</given-names></name><name><surname>Brock</surname> <given-names>MV</given-names></name><name><surname>Matsui</surname> <given-names>W</given-names></name><name><surname>Nelkin</surname> <given-names>BD</given-names></name><name><surname>Ball</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung Cancer</article-title><source>Cancer Research</source><volume>69</volume><fpage>845</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-2762</pub-id><pub-id pub-id-type="pmid">19176379</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Boareto</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Onuchic</surname> <given-names>JN</given-names></name><name><surname>Clementi</surname> <given-names>C</given-names></name><name><surname>Ben-Jacob</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Operating principles of Notch–Delta–Jagged module of cell–cell communication</article-title><source>New Journal of Physics</source><volume>17</volume><elocation-id>055021</elocation-id><pub-id pub-id-type="doi">10.1088/1367-2630/17/5/055021</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Kulkarni</surname> <given-names>P</given-names></name><name><surname>Weninger</surname> <given-names>K</given-names></name><name><surname>Orban</surname> <given-names>J</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phenotypic plasticity, Bet-Hedging, and androgen independence in prostate Cancer: role of Non-Genetic heterogeneity</article-title><source>Frontiers in Oncology</source><volume>8</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3389/fonc.2018.00050</pub-id><pub-id pub-id-type="pmid">29560343</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Celià-Terrassa</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamics of phenotypic heterogeneity associated with EMT and stemness during Cancer progression</article-title><source>Journal of Clinical Medicine</source><volume>8</volume><elocation-id>1542</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8101542</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Farquhar</surname> <given-names>KS</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name><name><surname>Frankenberger</surname> <given-names>CA</given-names></name><name><surname>Bevilacqua</surname> <given-names>E</given-names></name><name><surname>Yeung</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>EJ</given-names></name><name><surname>Balázsi</surname> <given-names>G</given-names></name><name><surname>Rosner</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions</article-title><source>PNAS</source><volume>111</volume><fpage>E364</fpage><lpage>E373</lpage><pub-id pub-id-type="doi">10.1073/pnas.1304840111</pub-id><pub-id pub-id-type="pmid">24395801</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Divergence measures based on the shannon entropy</article-title><source>IEEE Transactions on Information Theory</source><volume>37</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1109/18.61115</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Gomoto</surname> <given-names>R</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Onuchic</surname> <given-names>J</given-names></name><name><surname>Ben-Jacob</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tristability in cancer-associated microRNA-TF chimera toggle switch</article-title><source>The Journal of Physical Chemistry B</source><volume>117</volume><fpage>13164</fpage><lpage>13174</lpage><pub-id pub-id-type="doi">10.1021/jp403156m</pub-id><pub-id pub-id-type="pmid">23679052</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>W</given-names></name><name><surname>Trusina</surname> <given-names>A</given-names></name><name><surname>El-Samad</surname> <given-names>H</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name><name><surname>Tang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Defining network topologies that can achieve biochemical adaptation</article-title><source>Cell</source><volume>138</volume><fpage>760</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.06.013</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McColl</surname> <given-names>K</given-names></name><name><surname>Wildey</surname> <given-names>G</given-names></name><name><surname>Sakre</surname> <given-names>N</given-names></name><name><surname>Lipka</surname> <given-names>MB</given-names></name><name><surname>Behtaj</surname> <given-names>M</given-names></name><name><surname>Kresak</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Velcheti</surname> <given-names>V</given-names></name><name><surname>Fu</surname> <given-names>P</given-names></name><name><surname>Dowlati</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung Cancer</article-title><source>Oncotarget</source><volume>8</volume><fpage>73745</fpage><lpage>73756</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.20572</pub-id><pub-id pub-id-type="pmid">29088741</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>M</given-names></name><name><surname>Paquet</surname> <given-names>A</given-names></name><name><surname>Arguel</surname> <given-names>MJ</given-names></name><name><surname>Peyre</surname> <given-names>L</given-names></name><name><surname>Gomes-Pereira</surname> <given-names>LC</given-names></name><name><surname>Lebrigand</surname> <given-names>K</given-names></name><name><surname>Mograbi</surname> <given-names>B</given-names></name><name><surname>Brest</surname> <given-names>P</given-names></name><name><surname>Waldmann</surname> <given-names>R</given-names></name><name><surname>Barbry</surname> <given-names>P</given-names></name><name><surname>Hofman</surname> <given-names>P</given-names></name><name><surname>Roux</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Profiling the Non-genetic origins of Cancer drug resistance with a Single-Cell functional genomics approach using predictive cell dynamics</article-title><source>Cell Systems</source><volume>11</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2020.08.019</pub-id><pub-id pub-id-type="pmid">33099406</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname> <given-names>H</given-names></name><name><surname>Kondo</surname> <given-names>Y</given-names></name><name><surname>Matsuda</surname> <given-names>M</given-names></name><name><surname>Aoki</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell-to-Cell heterogeneity in p38-Mediated Cross-Inhibition of JNK causes stochastic cell death</article-title><source>Cell Reports</source><volume>24</volume><fpage>2658</fpage><lpage>2668</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.020</pub-id><pub-id pub-id-type="pmid">30184500</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname> <given-names>A</given-names></name><name><surname>Nam</surname> <given-names>A</given-names></name><name><surname>Pozhitkov</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Srivastava</surname> <given-names>S</given-names></name><name><surname>Nathan</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Mambetsariev</surname> <given-names>I</given-names></name><name><surname>Nelson</surname> <given-names>M</given-names></name><name><surname>Subbalakshmi</surname> <given-names>AR</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Nasser</surname> <given-names>MW</given-names></name><name><surname>Batra</surname> <given-names>SK</given-names></name><name><surname>Orban</surname> <given-names>J</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Massarelli</surname> <given-names>E</given-names></name><name><surname>Kulkarni</surname> <given-names>P</given-names></name><name><surname>Salgia</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Non-genetic mechanism involving the integrin β4/Paxillin Axis contributes to chemoresistance in lung Cancer</article-title><source>iScience</source><volume>23</volume><elocation-id>101496</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101496</pub-id><pub-id pub-id-type="pmid">32947124</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollaoglu</surname> <given-names>G</given-names></name><name><surname>Guthrie</surname> <given-names>MR</given-names></name><name><surname>Böhm</surname> <given-names>S</given-names></name><name><surname>Brägelmann</surname> <given-names>J</given-names></name><name><surname>Can</surname> <given-names>I</given-names></name><name><surname>Ballieu</surname> <given-names>PM</given-names></name><name><surname>Marx</surname> <given-names>A</given-names></name><name><surname>George</surname> <given-names>J</given-names></name><name><surname>Heinen</surname> <given-names>C</given-names></name><name><surname>Chalishazar</surname> <given-names>MD</given-names></name><name><surname>Cheng</surname> <given-names>H</given-names></name><name><surname>Ireland</surname> <given-names>AS</given-names></name><name><surname>Denning</surname> <given-names>KE</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>A</given-names></name><name><surname>Vahrenkamp</surname> <given-names>JM</given-names></name><name><surname>Berrett</surname> <given-names>KC</given-names></name><name><surname>Mosbruger</surname> <given-names>TL</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Kohan</surname> <given-names>JL</given-names></name><name><surname>Salama</surname> <given-names>ME</given-names></name><name><surname>Witt</surname> <given-names>BL</given-names></name><name><surname>Peifer</surname> <given-names>M</given-names></name><name><surname>Thomas</surname> <given-names>RK</given-names></name><name><surname>Gertz</surname> <given-names>J</given-names></name><name><surname>Johnson</surname> <given-names>JE</given-names></name><name><surname>Gazdar</surname> <given-names>AF</given-names></name><name><surname>Wechsler-Reya</surname> <given-names>RJ</given-names></name><name><surname>Sos</surname> <given-names>ML</given-names></name><name><surname>Oliver</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MYC drives progression of small cell lung Cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition</article-title><source>Cancer Cell</source><volume>31</volume><fpage>270</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.12.005</pub-id><pub-id pub-id-type="pmid">28089889</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orgogozo</surname> <given-names>V</given-names></name><name><surname>Morizot</surname> <given-names>B</given-names></name><name><surname>Martin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The differential view of genotype-phenotype relationships</article-title><source>Frontiers in Genetics</source><volume>6</volume><elocation-id>179</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2015.00179</pub-id><pub-id pub-id-type="pmid">26042146</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne</surname> <given-names>JK</given-names></name><name><surname>Larsen</surname> <given-names>JE</given-names></name><name><surname>Shields</surname> <given-names>MD</given-names></name><name><surname>Gonzales</surname> <given-names>JX</given-names></name><name><surname>Shames</surname> <given-names>DS</given-names></name><name><surname>Sato</surname> <given-names>M</given-names></name><name><surname>Kulkarni</surname> <given-names>A</given-names></name><name><surname>Wistuba</surname> <given-names>II</given-names></name><name><surname>Girard</surname> <given-names>L</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name><name><surname>Cobb</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM</article-title><source>PNAS</source><volume>110</volume><fpage>6524</fpage><lpage>6529</lpage><pub-id pub-id-type="doi">10.1073/pnas.1303932110</pub-id><pub-id pub-id-type="pmid">23553831</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearsall</surname> <given-names>SM</given-names></name><name><surname>Humphrey</surname> <given-names>S</given-names></name><name><surname>Revill</surname> <given-names>M</given-names></name><name><surname>Morgan</surname> <given-names>D</given-names></name><name><surname>Frese</surname> <given-names>KK</given-names></name><name><surname>Galvin</surname> <given-names>M</given-names></name><name><surname>Kerr</surname> <given-names>A</given-names></name><name><surname>Carter</surname> <given-names>M</given-names></name><name><surname>Priest</surname> <given-names>L</given-names></name><name><surname>Blackhall</surname> <given-names>F</given-names></name><name><surname>Simpson</surname> <given-names>KL</given-names></name><name><surname>Dive</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The rare YAP1 subtype of SCLC revisited in a biobank of 39 circulating tumor cell patient derived explant models: a brief report</article-title><source>Journal of Thoracic Oncology</source><volume>15</volume><fpage>1836</fpage><lpage>1843</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2020.07.008</pub-id><pub-id pub-id-type="pmid">32721553</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisco</surname> <given-names>AO</given-names></name><name><surname>Brock</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Moor</surname> <given-names>A</given-names></name><name><surname>Mojtahedi</surname> <given-names>M</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Non-Darwinian dynamics in therapy-induced Cancer drug resistance</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>2467</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3467</pub-id><pub-id pub-id-type="pmid">24045430</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname> <given-names>JT</given-names></name><name><surname>Dobromilskaya</surname> <given-names>I</given-names></name><name><surname>Moriarty</surname> <given-names>WF</given-names></name><name><surname>Peacock</surname> <given-names>CD</given-names></name><name><surname>Hann</surname> <given-names>CL</given-names></name><name><surname>Rudin</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Selective tropism of Seneca Valley virus for variant subtype small cell lung Cancer</article-title><source>JNCI: Journal of the National Cancer Institute</source><volume>105</volume><fpage>1059</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1093/jnci/djt130</pub-id><pub-id pub-id-type="pmid">23739064</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname> <given-names>JT</given-names></name><name><surname>Gardner</surname> <given-names>EE</given-names></name><name><surname>Connis</surname> <given-names>N</given-names></name><name><surname>Moreira</surname> <given-names>AL</given-names></name><name><surname>de Stanchina</surname> <given-names>E</given-names></name><name><surname>Hann</surname> <given-names>CL</given-names></name><name><surname>Rudin</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>DNA methylation in small cell lung Cancer defines distinct disease subtypes and correlates with high expression of EZH2</article-title><source>Oncogene</source><volume>34</volume><fpage>5869</fpage><lpage>5878</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.38</pub-id><pub-id pub-id-type="pmid">25746006</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname> <given-names>M</given-names></name><name><surname>Rajaram</surname> <given-names>S</given-names></name><name><surname>Steininger</surname> <given-names>RJ</given-names></name><name><surname>Osipchuk</surname> <given-names>D</given-names></name><name><surname>Roth</surname> <given-names>MA</given-names></name><name><surname>Morinishi</surname> <given-names>LS</given-names></name><name><surname>Evans</surname> <given-names>L</given-names></name><name><surname>Ji</surname> <given-names>W</given-names></name><name><surname>Hsu</surname> <given-names>CH</given-names></name><name><surname>Thurley</surname> <given-names>K</given-names></name><name><surname>Wei</surname> <given-names>S</given-names></name><name><surname>Zhou</surname> <given-names>A</given-names></name><name><surname>Koduru</surname> <given-names>PR</given-names></name><name><surname>Posner</surname> <given-names>BA</given-names></name><name><surname>Wu</surname> <given-names>LF</given-names></name><name><surname>Altschuler</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diverse drug-resistance mechanisms can emerge from drug-tolerant Cancer persister cells</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10690</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10690</pub-id><pub-id pub-id-type="pmid">26891683</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudin</surname> <given-names>CM</given-names></name><name><surname>Poirier</surname> <given-names>JT</given-names></name><name><surname>Byers</surname> <given-names>LA</given-names></name><name><surname>Dive</surname> <given-names>C</given-names></name><name><surname>Dowlati</surname> <given-names>A</given-names></name><name><surname>George</surname> <given-names>J</given-names></name><name><surname>Heymach</surname> <given-names>JV</given-names></name><name><surname>Johnson</surname> <given-names>JE</given-names></name><name><surname>Lehman</surname> <given-names>JM</given-names></name><name><surname>MacPherson</surname> <given-names>D</given-names></name><name><surname>Massion</surname> <given-names>PP</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name><name><surname>Oliver</surname> <given-names>TG</given-names></name><name><surname>Quaranta</surname> <given-names>V</given-names></name><name><surname>Sage</surname> <given-names>J</given-names></name><name><surname>Thomas</surname> <given-names>RK</given-names></name><name><surname>Vakoc</surname> <given-names>CR</given-names></name><name><surname>Gazdar</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Molecular subtypes of small cell lung Cancer: a synthesis of human and mouse model data</article-title><source>Nature Reviews Cancer</source><volume>19</volume><fpage>289</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0133-9</pub-id><pub-id pub-id-type="pmid">30926931</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahoo</surname> <given-names>S</given-names></name><name><surname>Singh</surname> <given-names>D</given-names></name><name><surname>Chakraborty</surname> <given-names>P</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Emergent properties of the HNF4α-PPARγ network may drive consequent phenotypic plasticity in NAFLD</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>870</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9030870</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgia</surname> <given-names>R</given-names></name><name><surname>Mambetsariev</surname> <given-names>I</given-names></name><name><surname>Hewelt</surname> <given-names>B</given-names></name><name><surname>Achuthan</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Poroyko</surname> <given-names>V</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Sattler</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modeling small cell lung Cancer (SCLC) biology through deterministic and stochastic mathematical models</article-title><source>Oncotarget</source><volume>9</volume><fpage>26226</fpage><lpage>26242</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.25360</pub-id><pub-id pub-id-type="pmid">29899855</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgia</surname> <given-names>R</given-names></name><name><surname>Kulkarni</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The genetic/Non-genetic duality of drug 'Resistance' in Cancer</article-title><source>Trends in Cancer</source><volume>4</volume><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2018.01.001</pub-id><pub-id pub-id-type="pmid">29458961</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santolini</surname> <given-names>M</given-names></name><name><surname>Barabási</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Predicting perturbation patterns from the topology of biological networks</article-title><source>PNAS</source><volume>115</volume><fpage>E6375</fpage><lpage>E6383</lpage><pub-id pub-id-type="doi">10.1073/pnas.1720589115</pub-id><pub-id pub-id-type="pmid">29925605</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname> <given-names>SM</given-names></name><name><surname>Dunagin</surname> <given-names>MC</given-names></name><name><surname>Torborg</surname> <given-names>SR</given-names></name><name><surname>Torre</surname> <given-names>EA</given-names></name><name><surname>Emert</surname> <given-names>B</given-names></name><name><surname>Krepler</surname> <given-names>C</given-names></name><name><surname>Beqiri</surname> <given-names>M</given-names></name><name><surname>Sproesser</surname> <given-names>K</given-names></name><name><surname>Brafford</surname> <given-names>PA</given-names></name><name><surname>Xiao</surname> <given-names>M</given-names></name><name><surname>Eggan</surname> <given-names>E</given-names></name><name><surname>Anastopoulos</surname> <given-names>IN</given-names></name><name><surname>Vargas-Garcia</surname> <given-names>CA</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Nathanson</surname> <given-names>KL</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rare cell variability and drug-induced reprogramming as a mode of Cancer drug resistance</article-title><source>Nature</source><volume>546</volume><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1038/nature22794</pub-id><pub-id pub-id-type="pmid">28607484</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>SV</given-names></name><name><surname>Lee</surname> <given-names>DY</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Quinlan</surname> <given-names>MP</given-names></name><name><surname>Takahashi</surname> <given-names>F</given-names></name><name><surname>Maheswaran</surname> <given-names>S</given-names></name><name><surname>McDermott</surname> <given-names>U</given-names></name><name><surname>Azizian</surname> <given-names>N</given-names></name><name><surname>Zou</surname> <given-names>L</given-names></name><name><surname>Fischbach</surname> <given-names>MA</given-names></name><name><surname>Wong</surname> <given-names>KK</given-names></name><name><surname>Brandstetter</surname> <given-names>K</given-names></name><name><surname>Wittner</surname> <given-names>B</given-names></name><name><surname>Ramaswamy</surname> <given-names>S</given-names></name><name><surname>Classon</surname> <given-names>M</given-names></name><name><surname>Settleman</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A chromatin-mediated reversible drug-tolerant state in Cancer cell subpopulations</article-title><source>Cell</source><volume>141</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.027</pub-id><pub-id pub-id-type="pmid">20371346</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Merritt</surname> <given-names>E</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Cruz</surname> <given-names>A</given-names></name><name><surname>Jiang</surname> <given-names>C</given-names></name><name><surname>Sarkodie</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Malhotra</surname> <given-names>J</given-names></name><name><surname>Riedlinger</surname> <given-names>GM</given-names></name><name><surname>De</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Non-Genetic Intra-Tumor heterogeneity is a major predictor of phenotypic heterogeneity and ongoing evolutionary dynamics in lung tumors</article-title><source>Cell Reports</source><volume>29</volume><fpage>2164</fpage><lpage>2174</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.10.045</pub-id><pub-id pub-id-type="pmid">31747591</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiraishi</surname> <given-names>T</given-names></name><name><surname>Matsuyama</surname> <given-names>S</given-names></name><name><surname>Kitano</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Large-Scale analysis of network bistability for human cancers</article-title><source>PLOS Computational Biology</source><volume>6</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000851</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname> <given-names>KL</given-names></name><name><surname>Stoney</surname> <given-names>R</given-names></name><name><surname>Frese</surname> <given-names>KK</given-names></name><name><surname>Simms</surname> <given-names>N</given-names></name><name><surname>Rowe</surname> <given-names>W</given-names></name><name><surname>Pearce</surname> <given-names>SP</given-names></name><name><surname>Humphrey</surname> <given-names>S</given-names></name><name><surname>Booth</surname> <given-names>L</given-names></name><name><surname>Morgan</surname> <given-names>D</given-names></name><name><surname>Dynowski</surname> <given-names>M</given-names></name><name><surname>Trapani</surname> <given-names>F</given-names></name><name><surname>Catozzi</surname> <given-names>A</given-names></name><name><surname>Revill</surname> <given-names>M</given-names></name><name><surname>Helps</surname> <given-names>T</given-names></name><name><surname>Galvin</surname> <given-names>M</given-names></name><name><surname>Girard</surname> <given-names>L</given-names></name><name><surname>Nonaka</surname> <given-names>D</given-names></name><name><surname>Carter</surname> <given-names>L</given-names></name><name><surname>Krebs</surname> <given-names>MG</given-names></name><name><surname>Cook</surname> <given-names>N</given-names></name><name><surname>Carter</surname> <given-names>M</given-names></name><name><surname>Priest</surname> <given-names>L</given-names></name><name><surname>Kerr</surname> <given-names>A</given-names></name><name><surname>Gazdar</surname> <given-names>AF</given-names></name><name><surname>Blackhall</surname> <given-names>F</given-names></name><name><surname>Dive</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A biobank of small cell lung Cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity</article-title><source>Nature Cancer</source><volume>1</volume><fpage>437</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/s43018-020-0046-2</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somarelli</surname> <given-names>JA</given-names></name><name><surname>Shetler</surname> <given-names>S</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Bartholf Dewitt</surname> <given-names>S</given-names></name><name><surname>Hish</surname> <given-names>AJ</given-names></name><name><surname>Gilja</surname> <given-names>S</given-names></name><name><surname>Eward</surname> <given-names>WC</given-names></name><name><surname>Ware</surname> <given-names>KE</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name><name><surname>Armstrong</surname> <given-names>AJ</given-names></name><name><surname>Garcia-Blanco</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mesenchymal-Epithelial transition in sarcomas is controlled by the combinatorial expression of MicroRNA 200s and GRHL2</article-title><source>Molecular and Cellular Biology</source><volume>36</volume><fpage>2503</fpage><lpage>2513</lpage><pub-id pub-id-type="doi">10.1128/MCB.00373-16</pub-id><pub-id pub-id-type="pmid">27402864</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Lei</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>K</given-names></name><name><surname>Tang</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>YAP1 promotes multidrug resistance of small cell lung Cancer by CD74-related signaling pathways</article-title><source>Cancer Medicine</source><volume>9</volume><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1002/cam4.2668</pub-id><pub-id pub-id-type="pmid">31692299</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname> <given-names>SL</given-names></name><name><surname>Gaudet</surname> <given-names>S</given-names></name><name><surname>Albeck</surname> <given-names>JG</given-names></name><name><surname>Burke</surname> <given-names>JM</given-names></name><name><surname>Sorger</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis</article-title><source>Nature</source><volume>459</volume><fpage>428</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1038/nature08012</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>CA</given-names></name><name><surname>Gay</surname> <given-names>CM</given-names></name><name><surname>Xi</surname> <given-names>Y</given-names></name><name><surname>Sivajothi</surname> <given-names>S</given-names></name><name><surname>Sivakamasundari</surname> <given-names>V</given-names></name><name><surname>Fujimoto</surname> <given-names>J</given-names></name><name><surname>Bolisetty</surname> <given-names>M</given-names></name><name><surname>Hartsfield</surname> <given-names>PM</given-names></name><name><surname>Balasubramaniyan</surname> <given-names>V</given-names></name><name><surname>Chalishazar</surname> <given-names>MD</given-names></name><name><surname>Moran</surname> <given-names>C</given-names></name><name><surname>Kalhor</surname> <given-names>N</given-names></name><name><surname>Stewart</surname> <given-names>J</given-names></name><name><surname>Tran</surname> <given-names>H</given-names></name><name><surname>Swisher</surname> <given-names>SG</given-names></name><name><surname>Roth</surname> <given-names>JA</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>de Groot</surname> <given-names>J</given-names></name><name><surname>Glisson</surname> <given-names>B</given-names></name><name><surname>Oliver</surname> <given-names>TG</given-names></name><name><surname>Heymach</surname> <given-names>JV</given-names></name><name><surname>Wistuba</surname> <given-names>I</given-names></name><name><surname>Robson</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Byers</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung Cancer</article-title><source>Nature Cancer</source><volume>1</volume><fpage>423</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1038/s43018-019-0020-z</pub-id><pub-id pub-id-type="pmid">33521652</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>Y</given-names></name><name><surname>Bintz</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Robert</surname> <given-names>L</given-names></name><name><surname>Ng</surname> <given-names>AHC</given-names></name><name><surname>Liu</surname> <given-names>V</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Heath</surname> <given-names>JR</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1007034</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1007034</pub-id><pub-id pub-id-type="pmid">31166947</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbiah</surname> <given-names>S</given-names></name><name><surname>Nam</surname> <given-names>A</given-names></name><name><surname>Garg</surname> <given-names>N</given-names></name><name><surname>Behal</surname> <given-names>A</given-names></name><name><surname>Kulkarni</surname> <given-names>P</given-names></name><name><surname>Salgia</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Small cell lung Cancer from traditional to innovative therapeutics: building a comprehensive network to optimize clinical and translational research</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>2433</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9082433</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlemsani</surname> <given-names>C</given-names></name><name><surname>Pongor</surname> <given-names>L</given-names></name><name><surname>Elloumi</surname> <given-names>F</given-names></name><name><surname>Girard</surname> <given-names>L</given-names></name><name><surname>Huffman</surname> <given-names>KE</given-names></name><name><surname>Roper</surname> <given-names>N</given-names></name><name><surname>Varma</surname> <given-names>S</given-names></name><name><surname>Luna</surname> <given-names>A</given-names></name><name><surname>Rajapakse</surname> <given-names>VN</given-names></name><name><surname>Sebastian</surname> <given-names>R</given-names></name><name><surname>Kohn</surname> <given-names>KW</given-names></name><name><surname>Krushkal</surname> <given-names>J</given-names></name><name><surname>Aladjem</surname> <given-names>MI</given-names></name><name><surname>Teicher</surname> <given-names>BA</given-names></name><name><surname>Meltzer</surname> <given-names>PS</given-names></name><name><surname>Reinhold</surname> <given-names>WC</given-names></name><name><surname>Minna</surname> <given-names>JD</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Pommier</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SCLC-CellMiner: a resource for small cell lung Cancer cell line genomics and pharmacology based on genomic signatures</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108296</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108296</pub-id><pub-id pub-id-type="pmid">33086069</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname> <given-names>S</given-names></name><name><surname>Chakraborty</surname> <given-names>P</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>A mechanism for epithelial-mesenchymal heterogeneity in a population of Cancer cells</article-title><source>PLOS Computational Biology</source><volume>16</volume><elocation-id>e1007619</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1007619</pub-id><pub-id pub-id-type="pmid">32040502</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname> <given-names>S</given-names></name><name><surname>Kessler</surname> <given-names>DA</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Biological networks regulating cell fate choice are minimally frustrated</article-title><source>Physical Review Letters</source><volume>125</volume><elocation-id>088101</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.125.088101</pub-id><pub-id pub-id-type="pmid">32909810</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname> <given-names>S</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name><name><surname>Jolly</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2020">2020c</year><article-title>The physics of cellular decision making during Epithelial-Mesenchymal transition</article-title><source>Annual Review of Biophysics</source><volume>49</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-121219-081557</pub-id><pub-id pub-id-type="pmid">31913665</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udyavar</surname> <given-names>AR</given-names></name><name><surname>Wooten</surname> <given-names>DJ</given-names></name><name><surname>Hoeksema</surname> <given-names>M</given-names></name><name><surname>Bansal</surname> <given-names>M</given-names></name><name><surname>Califano</surname> <given-names>A</given-names></name><name><surname>Estrada</surname> <given-names>L</given-names></name><name><surname>Schnell</surname> <given-names>S</given-names></name><name><surname>Irish</surname> <given-names>JM</given-names></name><name><surname>Massion</surname> <given-names>PP</given-names></name><name><surname>Quaranta</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel hybrid phenotype revealed in small cell lung Cancer by a transcription factor network model that can explain tumor heterogeneity</article-title><source>Cancer Research</source><volume>77</volume><fpage>1063</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-1467</pub-id><pub-id pub-id-type="pmid">27932399</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Boxtel</surname> <given-names>C</given-names></name><name><surname>van Heerden</surname> <given-names>JH</given-names></name><name><surname>Nordholt</surname> <given-names>N</given-names></name><name><surname>Schmidt</surname> <given-names>P</given-names></name><name><surname>Bruggeman</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Taking chances and making mistakes: non-genetic phenotypic heterogeneity and its consequences for surviving in dynamic environments</article-title><source>Journal of the Royal Society Interface</source><volume>14</volume><elocation-id>20170141</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2017.0141</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varahan</surname> <given-names>S</given-names></name><name><surname>Walvekar</surname> <given-names>A</given-names></name><name><surname>Sinha</surname> <given-names>V</given-names></name><name><surname>Krishna</surname> <given-names>S</given-names></name><name><surname>Laxman</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic constraints drive self-organization of specialized cell groups</article-title><source>eLife</source><volume>8</volume><elocation-id>e46735</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46735</pub-id><pub-id pub-id-type="pmid">31241462</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname> <given-names>LS</given-names></name><name><surname>Burnett</surname> <given-names>JC</given-names></name><name><surname>Toettcher</surname> <given-names>JE</given-names></name><name><surname>Arkin</surname> <given-names>AP</given-names></name><name><surname>Schaffer</surname> <given-names>DV</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Stochastic gene expression in a lentiviral positive-feedback loop: hiv-1 tat fluctuations drive phenotypic diversity</article-title><source>Cell</source><volume>122</volume><fpage>169</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.06.006</pub-id><pub-id pub-id-type="pmid">16051143</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname> <given-names>DR</given-names></name><name><surname>Hurst</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Defining the hallmarks of metastasis</article-title><source>Cancer Research</source><volume>79</volume><fpage>3011</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-0458</pub-id><pub-id pub-id-type="pmid">31053634</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname> <given-names>DJ</given-names></name><name><surname>Groves</surname> <given-names>SM</given-names></name><name><surname>Tyson</surname> <given-names>DR</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Lim</surname> <given-names>JS</given-names></name><name><surname>Albert</surname> <given-names>R</given-names></name><name><surname>Lopez</surname> <given-names>CF</given-names></name><name><surname>Sage</surname> <given-names>J</given-names></name><name><surname>Quaranta</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Systems-level network modeling of small cell lung Cancer subtypes identifies master regulators and destabilizers</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1007343</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1007343</pub-id><pub-id pub-id-type="pmid">31671086</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname> <given-names>DJ</given-names></name><name><surname>Quaranta</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mathematical models of cell phenotype regulation and reprogramming: make Cancer cells sensitive again!</article-title><source>Biochimica Et Biophysica Acta (BBA) - Reviews on Cancer</source><volume>1867</volume><fpage>167</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2017.04.001</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname> <given-names>SK</given-names></name><name><surname>Guan</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Breast Cancer: multiple subtypes within a tumor?</article-title><source>Trends in Cancer</source><volume>3</volume><fpage>753</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2017.09.001</pub-id><pub-id pub-id-type="pmid">29120751</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Jia</surname> <given-names>D</given-names></name><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Ben-Jacob</surname> <given-names>E</given-names></name><name><surname>Levine</surname> <given-names>H</given-names></name><name><surname>Kaipparettu</surname> <given-names>BA</given-names></name><name><surname>Onuchic</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modeling the genetic regulation of Cancer metabolism: interplay between glycolysis and oxidative phosphorylation</article-title><source>Cancer Research</source><volume>77</volume><fpage>1564</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-2074</pub-id><pub-id pub-id-type="pmid">28202516</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>JX</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Understanding gene circuits at cell-fate branch points for rational cell reprogramming</article-title><source>Trends in Genetics</source><volume>27</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2010.11.002</pub-id><pub-id pub-id-type="pmid">21146896</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64522.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Krishna</surname><given-names>Sandeep</given-names></name><role>Reviewing Editor</role><aff><institution>National Centre for Biological Sciences‐Tata Institute of Fundamental Research</institution><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Clairambault</surname><given-names>Jean</given-names> </name><role>Reviewer</role></contrib><contrib contrib-type="reviewer"><name><surname>Wooten</surname><given-names>David</given-names> </name><role>Reviewer</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper provides a detailed analysis of the master regulatory network involved in small cell lung cancer. Using multiple mathematical tools, the authors transform a complex, highly connected network into a small, easy-to-interpret reduced form. The reduced network provides insight into the topological features – here the existence of two &quot;teams&quot; of genes that inhibit each other – that determine the non-genetic phenotypic plasticity in these cancer cells. The concordance between the reduced network and experimental knowledge from the field suggest that these methods may be useful more broadly to make sense of complex regulatory networks elsewhere.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Aleksandra Walczak as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Jean Clairambault (Reviewer #1); David Wooten (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The reviewers appreciated your detailed analysis of the regulatory network involved in small cell lung cancer. However, they also raise some concerns that are expressed in the reviews appended below. In your revision, please try to address the concerns of the reviewers, in particular please expand your analysis and comparison to similar results in literature (Reviewer 2) and discuss how your methods could be generalized to apply to other networks (Reviewer 3).</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p><italic>Reviewer #1:</italic></p><p>Detailed study of the master regulatory network of SCLC by probabilistic methods, focusing on the two genes ASCL1 and NEUROD1. Supports by up-to-date literature reports and sound gene expression analysis the non-genetic phenotypic plasticity of SCLC cells. May be a major step forward in understanding non-genetic phenotype plasticity in cancer.</p><p>Firstly, let me say that the technical aspects of this very detailed study go far beyond my field of expertise. I will evaluate it from an external eye, and according to the contribution it brings to the investigation of non genetic phenotype plasticity in cancer, here focusing on small cell lung cancer (SCLC). Plasticity in cancer cells is indeed a major field of research nowadays, resulting in metastasis and drug persistence/tolerance, and especially SCLC has escaped efficacious treatments until now.</p><p>As far as I could understand the analysis, by two different methods, one based on Boolean networks, the other on elementary (nevertheless of great dimensionality) ordinary differential equations, the authors statistically “shake” the possible parameters of the regulatory network of genes found “masterly” expressed in SCLC, according to a study of 2017 (Udyavar et al., 2017), network in which one can recognize 3 of the 4 Yamanaka genes, MYC, KLF4 and <italic>SOX2</italic>.</p><p>Rather than on the Yamanaka genes, the authors focus on the two genes ASCL1 and NEUROD1, for both of which they find marked differential expression (high/low), resulting in 4 different coupled phenotypes at the gene expression level, which, as “patterns of steady states seen in influence and correlation matrices”, correlate with experimental results collected from experimental data on SCLC. Indeed, ASCL1 and NEUROD1 had already been identified as master regulators of the salient gene network of SCLC, ASCL1 being a neuroendocrine marker and NEUROD1 being associated with mesenchymal markers susceptible of inducing metastasis, i.e., two markers of plasticity.</p><p>The design of this analysis relies on an apparently complete analysis of the scientific literature on both the subject of non-genetic phenotypic heterogeneity and the particular case go gene expression studies on SCLC. The results reported by the authors support by gene expression analyses the idea that within the same genomic status of SCLC cells, different steady states in gene expression lead to different phenotypic states (multistability) that are found experimentally. Although no clear therapeutic perspective for SCLC emerges from this study, it is an interesting step to better understand the plasticity of SCLC cells, possibly resulting in their drug tolerance and thus escaping treatments so far.</p><p>For these reasons, I propose that this study be published as it is in <italic>eLife</italic>.</p><p><italic>Reviewer #2:</italic></p><p>This paper will be of interest to researchers working on the origins of cellular heterogeneity in cancer. Using network and gene expression analysis, previous known findings on the potential role of topology in generating four broad cellular states in small cell lung cancer (SCLC) are confirmed here. Interestingly, it is observed that both discrete and continuous gene expression models can give rise to similar steady states. Two modules of genes inhibiting each other are found to lead to the four emergent states in SCLC. However, these results are not well compared and contrasted in the context of prior literature.</p><p>Chauhan, et al. investigate the origins of cellular heterogeneity in Small Cell Lung Cancer. Previous experimental work has classified four major states based upon the expression levels of Ascl1 and Neurod1 genes, along with other states. Previous computational work based on Boolean networks (Wooten et al., 2019 and Udyavar et al., 2017) suggested these four states may arise naturally as the steady states of the underlying gene-interaction network in SCLC.</p><p>Here the authors re-analyze the SCLC gene-interaction network based on a Boolean framework with an underlying Ising hamiltonian. They show that the four major states based on Ascl1 and Neurod1 can be recovered from dynamic simulations of the 33 node 357 edge network. While not surprising in the light of prior work, the authors successfully demonstrate that a somewhat different Boolean framework leads to similar results, suggesting the underlying topology is indeed important for generating cellular heterogeneity. However, it is not clear whether this formalism based upon the Ising Model improves upon the previously used Boolean framework (Wooten et al. and Udyavar et al) in any way.</p><p>The authors then model the dynamics of the gene network using ODEs, allowing continuous values for the expression levels of the nodes. 4 of the top 10 frequent steady states corresponded to the 4 states found earlier. However, these 4 states have much lower frequency (adding up to only about 22%) whereas in the Boolean framework the frequencies added up to almost 100%. The identity and frequencies of the remaining 6 out of 10 frequent states is not discussed.</p><p>Using a pairwise correlation strategy for all the nodes, the authors then uncover an interesting result: the nodes fall into two modules that repress each other. This also seems to be true in two publicly available gene expression datasets. Surprisingly, Neurod1 did not appear in these modules and it is unclear why, given the four main states are defined based on Neurod1 and Ascl1 expression levels. The two modules are also distinct from the higher number of modules found earlier (Wooten et al., 2019), and it is unclear why these differences arise.</p><p>Finally, using a series of clustering algorithms (hierarchical and K-means clustering, UMAP) on gene expression datasets, the authors show that not only the 4 states based on Neurod1 and Ascl1, but also further states based on Pou2f3 and Yap1 expression levels can be recovered. However, the authors use only a few genes of interest in performing the clustering and it is not clear why all the available genes were not used.</p><p>In my opinion, the most significant area where this manuscript needs to be strengthened is in providing critical comparisons with prior literature and results (primarily Wooten et al and Udyavar et al). Discussions on what advances have been made in this paper with respect to what was already known earlier, need to be highlighted. I found it quite hard to judge this manuscript and place it in context, since a lot of the methods and datasets used here are very similar to the previous works. Detailed suggestions along these lines as well as some possible new analyses are provided below:</p><p>1) It would be good to know why the authors chose an Ising Model – based Boolean simulation strategy as compared to the Boolean model used in Wooten at al. Is there some difference in the statistics expected from these two different formalisms? Is there some limitation of the previous work that the authors wanted to address here? Given that Wooten et al. showed that the 4 SCLC states can be recapitulated, is it surprising that the authors get the same 4 states using their Boolean method on an identical network?</p><p>2) For the ODE method, the frequency of the four states add up to only about 22%. It would be interesting to see a full list of the top ten states with their frequencies, and a discussion on why these other states appear in the ODE but not in the Boolean formalism and its biological implications.</p><p>3) Following up on point (2) above, was there a reason for using two separate axes for the same quantity (frequency) in Figure 1D i ? I found this quite confusing, because for example, at first sight it seems like the S2 steady state has similar frequencies in RACIPE vs Boolean. But the frequencies are in reality very different, right? I would therefore suggest to plot both RACIPE and Boolean results using just one axis, to avoid confusion.</p><p>4) The observation of two &quot;modules&quot; using pair-wise correlations is interesting. However, it was unclear to me why Wooten et al. find 17-18 modules, though their WGCNA method also uses a pair-wise gene correlation technique. A detailed discussion on this would be very helpful for readers in my opinion.</p><p>5) Related to the pair-wise correlation method, I was surprised to see that Neurod1 does not seem to be part of any module in Figure 2. In the Discussion, the authors mention that Ascl1 and Neurod1 don't fall in the same team, but it seems to me from Figure 2 that Neurod1 doesn't belong to any team! This seems to be contradictory to the rest of the results, unless I have misunderstood something here. A discussion on these lines seems warranted.</p><p>6) Given that the dynamical simulations were carried out with 33 genes, why did the authors choose to perform all the clustering analyses with only a handful of genes? This may be problematic, for example, if sets of 2 or 4 randomly chosen genes are used for clustering the expression datasets, how likely are we to find a few well separated clusters? If we find that random gene subsets also separate into clusters, how biologically meaningful is it to see clusters with Ascl1 and Neurod1?</p><p><italic>Reviewer #3:</italic></p><p>This work by Chauhan et al. finds order from complexity. Using multiple mathematical tools, they transform a complex, highly connected network into a small, easy-to-interpret reduced form. The concordance between their reduced network and experimental knowledge from the field support the insights they gained from their analysis here, and that their methods may be useful more broadly to make sense of complex networks elsewhere.</p><p>The final findings (Figures 4-5) on experimental data, which show that just a few genes can reproduce the full-spectrum of known SCLC heterogeneity seem to strongly support the authors' primary conclusions. Specifically, a system which is well classifiable using a few nodes closely matches my expectation for a network that can be reduced to a few tightly connected groups of nodes.</p><p>The agreement between Boolean and RACIPE greatly strengthen their results.</p><p>The J metric is interesting, and while it would be beyond the scope of this work, I would be very interested in seeing it applied to other networks to see how generalizable its interpretation is. However, the definition is tightly coupled to the 33 genes in this network, and their pattern of expression in the steady states. Discussion about how the metric could generalized would strengthen the manuscript.</p><p>I found it very interesting that not only Neurod1, but also Elf3 was pulled out as an individual node in the reduced form. In another work (Wooten et al., 2019), the authors identified ELF3 as a master regulator of one of their subtypes (NEv2). The identification of this node through topological features here also lends further credence to the influence matrix.</p><p>The authors state that &quot;These results suggest that influence matrix is a better representation of network topology as compared to the interaction matrix.&quot;. However, since the influence matrix comes from the interaction matrix, it seems like it necessarily contains less information. The authors make this claim based on the fact that a network reduction based on influence matrix more closely represents the steady state distributions than a similar reduction based on interaction matrix. But it is not clear how much this conclusion is specific to this particular network, or reduction strategy.</p><p>The correspondence of the steady states with expression data appears quite promising! However, the fact that Neurod1 is the sole gene that distinguishes S1 from S4, or S2 from S3, makes me suspect other genes must also contribute to the difference? Are there other genes in the literature that the authors think could be included into new versions the network that could give a broader picture of the differences between S1 vs S4, or S2 vs S3? Given the other 31 nodes in the network, do their steady state values more closely match one or another cluster from Figure 4B?</p><p>When introducing the Font-Clos s<sub>i</sub>(t+1) equation, I recommend to describe what happens if s<sub>i</sub>=0, rather than just including that info in supplement.</p><p>Figure 1B should have a legend indicating dark=off, blank=on (even though it is in the caption)</p><p>I do not see what test / method was used to find the +/- % confidence intervals in Figure 1B, nor what size interval they represent (e.g., 95%?)</p><p>The reference in-text to Figure 1C, i, regarding swapping random edges, seems to actually refer to both i and ii</p><p>In the text, the connection between the larger number of steady states of &quot;random&quot; networks to the true network's topology lacks a relevant reference to Figure 1C, iii</p><p>The text introducing the J metric should describe what the indices are, rather than requiring the reader to search the figure.</p><p>The introduction of influence matrix was very hard to follow, the grammar is confusing, and &quot;lmax&quot; is not clearly described in the main text, even though it is used several times.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Aleksandra Walczak (Senior Editor) and a Reviewing Editor.</p><p>The reviewers are happy with the revisions you have made and the paper is almost ready for acceptance, but one substantive point raised by Reviewer 2 remains (see below). Please try to perform clustering analysis for randomly chosen sets of 2 genes (other than ASCL1 and NEUROD1). If these don't result in well-separate clusters it strengthens your result, but if they do then you can modify your statements accordingly, for instance by expanding on other biological reasons to focus on ASLC1 and NEUROD1 based clustering. Alternatively, if you feel such clustering based on randomly chosen genes is not useful, please provide some reasons why you think so.</p><p><italic>Reviewer #2:</italic></p><p>The authors have now satisfactorily responded to most of the comments/queries.</p><p>Their response to point (6) that I had raised is not entirely satisfactory however, since they do not seem to have addressed the randomization point that I had raised. If random sets of two (or more) genes are chosen for the clustering analysis, how often do we see well separated clusters? It seems to me an important point to analyze and understand, in order to put the ASCL1 and Neurod1 based clustering in perspective. I would strongly urge the authors to include this analysis, unless they feel this is not a sensible question to address, in which case it would be good to hear their arguments against this.</p><p><italic>Reviewer #3:</italic></p><p>The revised manuscript addresses my original comments, and I support its publication.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64522.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>In my opinion, the most significant area where this manuscript needs to be strengthened is in providing critical comparisons with prior literature and results (primarily Wooten at al and Udyavar et al). Discussions on what advances have been made in this paper with respect to what was already known earlier, need to be highlighted. I found it quite hard to judge this manuscript and place it in context, since a lot of the methods and datasets used here are very similar to the previous works. Detailed suggestions along these lines as well as some possible new analyses are provided below:</p><p>1) It would be good to know why the authors chose an Ising Model – based Boolean simulation strategy as compared to the Boolean model used in Wooten at al. Is there some difference in the statistics expected from these two different formalisms? Is there some limitation of the previous work that the authors wanted to address here? Given that Wooten et al. showed that the 4 SCLC states can be recapitulated, is it surprising that the authors get the same 4 states using their Boolean method on an identical network?</p></disp-quote><p>We thank the reviewer for this important question. Udyavar et al., 2017 – the precursor manuscript to Wooten et al., 2019 – had also used the Ising model-based Boolean simulation strategy. Thus, as far as Figure 1B is concerned, these are for the same circuit (Figure 1A) and modeling strategy as in Udyavar et al.</p><p>Wooten et al. have used a different network than what was used in Udyavar et al. and also a different modeling strategy (BooleaBayes) which depends on inferring logical relationships between nodes in gene regulatory networks using gene expression data and using a “Bayes-like adjustment approach”. Therefore, the network Wooten et al. arrived at using BooleaBayes (Figure 7A) is different from the one we and Udyavar et al. have used. Hence, obtaining 4 states in this network may not necessarily be surprising as far as SCLC phenotypes are concerned. However, obtaining only four states from such a complex network (33 nodes, 357 edges) was very intriguing to us, which drove further our investigations in network topology-based analysis.</p><p>The key message in our manuscript is not that this network has only four states, but the reasons for why only four states are seen in this complex and large network (33 nodes, 357 edges). We have deciphered a “latent” design principle in SCLC network, and have offered a conceptual framework to decode similar design principles hidden in other regulatory networks.</p><p>Moreover, in addition to running Ising model based simulations for the network, we have used a parameter-agnostic approach – RACIPE – and notice at least a semi-quantitative agreement in terms of dominance of the four states identified via Ising model. This agreement strengthens our key point that network topology alone can contain enough information about its dynamics. We have now added a paragraph in the Discussion section highlighting these salient points.</p><disp-quote content-type="editor-comment"><p>2) For the ODE method, the frequency of the four states add up to only about 22%. It would be interesting to see a full list of the top ten states with their frequencies, and a discussion on why these other states appear in the ODE but not in the Boolean formalism and its biological implications.</p></disp-quote><p>We thank the reviewer for this subtle observation and raising this important question. We have now performed a detailed analysis of top 20 states obtained by RACIPE whose frequencies add up to 54%, and observed that these 20 states are very similar to the top 4 states obtained by Boolean (X1-X4 in Figure 1B), with a difference noted in only one or two nodes (i.e. node value = 0 in Boolean state and 1 in RACIPE state or <italic>vice versa</italic>).</p><p>It is not surprising to see that the RACIPE output has a much larger number of states than Boolean output, given its continuous nature, an observation we made in our previous manuscript as well (Hari et al., 2020) and is now included in a new paragraph in the Discussion.</p><p>Conceptually speaking, given that the sizes of the two “groups” identified are 22 and 10 nodes, a difference in values of one or two nodes are not very likely to give rise to a completely different biological phenotype. Thus, these “close-enough” states can be thought of as “micro-states” that overall constitute a biological “macro-state” or phenotype.</p><disp-quote content-type="editor-comment"><p>3) Following up on point (2) above, was there a reason for using two separate axes for the same quantity (frequency) in Figure 1D i ? I found this quite confusing, because for example, at first sight it seems like the S2 steady state has similar frequencies in RACIPE vs Boolean. But the frequencies are in reality very different, right? I would therefore suggest to plot both RACIPE and Boolean results using just one axis, to avoid confusion.</p></disp-quote><p>Thanks to the additional analysis performed (mentioned in response to point (2)); we have now replaced Figure 1D i to address this point.</p><disp-quote content-type="editor-comment"><p>4) The observation of two &quot;modules&quot; using pair-wise correlations is interesting. However, it was unclear to me why Wooten et al. find 17-18 modules, though their WGCNA method also uses a pair-wise gene correlation technique. A detailed discussion on this would be very helpful for readers in my opinion.</p></disp-quote><p>The WGCNA method gives us correlation data from all the genes whose expression values are used as an input to the algorithm. It is a statistical method that works on threshold based correlation, and does not use any mechanistic information embedded in a network topology. Because network topology information is not required, Wooten et al. were able to start with a much larger set of genes and obtain a large number of modules. Not surprisingly, we found that the 33 genes considered here were spread across different modules. This is not surprising or contradictory because any of these 33 genes can still be correlated strongly with any other gene not in the network simulated here, and those genes may belong to different modules. It should be noted that two genes can show a good correlation in their gene expression values without any of them directly or indirectly affecting each other, say transcription factor activates gene B but inhibits gene C, thus, B and C are most likely to be negatively correlated. In brief, our analysis is based on network topology, not transcriptomic data that is input to WCGNA. This point is now included in a new paragraph added in the Discussion section.</p><disp-quote content-type="editor-comment"><p>5) Related to the pair-wise correlation method, I was surprised to see that Neurod1 does not seem to be part of any module in Figure 2. In the Discussion, the authors mention that Ascl1 and Neurod1 don't fall in the same team, but it seems to me from Figure 2 that Neurod1 doesn't belong to any team! This seems to be contradictory to the rest of the results, unless I have misunderstood something here. A discussion on these lines seems warranted.</p></disp-quote><p>We apologize for a potential semantic confusion caused. The two statements – “NEUROD1 does not belong in the same team as ASCL1” and “NEUROD1 does not belong to either of the two teams” – are not contradictory to one another. We have performed further analysis based on CCLE and GSE73160 gene expression values and see that NEUROD1 levels do not align with the patterns seen in the expression values of members of two groups (Figure 4—figure supplement 2).</p><disp-quote content-type="editor-comment"><p>6) Given that the dynamical simulations were carried out with 33 genes, why did the authors choose to perform all the clustering analyses with only a handful of genes? This may be problematic, for example, if sets of 2 or 4 randomly chosen genes are used for clustering the expression datasets, how likely are we to find a few well separated clusters? If we find that random gene subsets also separate into clusters, how biologically meaningful is it to see clusters with Ascl1 and Neurod1?</p></disp-quote><p>Our reason to include ASCL1 and NEUROD1 based clustering was purely based on available experimental literature suggesting these two nodes as key markers and/or inducers of phenotypic heterogeneity in SCLC. In the latter half of our analysis (Figure 5), we have used YAP1 and POU2F3 in addition to ASCL1 and NEUROD1 to classify CCLE SCLC cell lines, but we do not have either of them as a part of the network in the first place. Again, their choice was made based on available literature in SCLC heterogeneity as mentioned by Wooten et al.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>[…]</p><p>The authors state that &quot;These results suggest that influence matrix is a better representation of network topology as compared to the interaction matrix.&quot;. However, since the influence matrix comes from the interaction matrix, it seems like it necessarily contains less information. The authors make this claim based on the fact that a network reduction based on influence matrix more closely represents the steady state distributions than a similar reduction based on interaction matrix. But it is not clear how much this conclusion is specific to this particular network, or reduction strategy.</p></disp-quote><p>We are grateful to the reviewer for encouraging remarks and we share the excitement about agreement in Boolean and RACIPE results, as well as a broader application of influence matrix. We have already seen preliminary evidence showing the two “teams” regulating phenotypic heterogeneity in other cancer-related signaling networks (for instance, see Figure 2 in Jia et al., 2020 – <ext-link ext-link-type="uri" xlink:href="https://www.oncotarget.com/article/27651/text/">https://www.oncotarget.com/article/27651/text/</ext-link>). Because these additional networks are not directly related to SCLC, we are not including those results in this manuscript, but influence matrix based analysis will be the focus of our upcoming manuscript(s).</p><disp-quote content-type="editor-comment"><p>The correspondence of the steady states with expression data appears quite promising! However, the fact that Neurod1 is the sole gene that distinguishes S1 from S4, or S2 from S3, makes me suspect other genes must also contribute to the difference? Are there other genes in the literature that the authors think could be included into new versions the network that could give a broader picture of the differences between S1 vs S4, or S2 vs S3? Given the other 31 nodes in the network, do their steady state values more closely match one or another cluster from Figure 4B?</p></disp-quote><p>We have included additional analysis (Figure 4—figure supplement 2) highlighting the expression of other nodes besides ASCL1 and NEUROD1. As expected, the two groups identified via influence matrix largely show similar trends, i.e. as compared to A-N- and A-N+ subgroups, members of group A (ASCL1 is one of them) have higher expression levels in A+N- and A+N+ samples while members of group B have lower expression levels in these two subgroups. This analysis suggests that while other genes could play a role in defining the subtypes, their contribution might not possess the distinguishing power of ASCL1 and NEUROD1.</p><disp-quote content-type="editor-comment"><p>When introducing the Font-Clos s<sub>i</sub>(t+1) equation, I recommend to describe what happens if s<sub>i</sub>=0, rather than just including that info in supplement.</p></disp-quote><p>We have now included the same.</p><disp-quote content-type="editor-comment"><p>Figure 1B should have a legend indicating dark=off, blank=on (even though it is in the caption)</p></disp-quote><p>We have included this legend in Figure 1B.</p><disp-quote content-type="editor-comment"><p>I do not see what test / method was used to find the +/- % confidence intervals in Figure 1B, nor what size interval they represent (e.g., 95%?)</p></disp-quote><p>We have now clarified it in the figure legend. The +/- % represent mean and standard deviation of the frequencies obtained across three independent Ising-model replicates.</p><disp-quote content-type="editor-comment"><p>The reference in-text to Figure 1C, i, regarding swapping random edges, seems to actually refer to both i and ii</p></disp-quote><p>We have now referred to both i and ii.</p><disp-quote content-type="editor-comment"><p>In the text, the connection between the larger number of steady states of &quot;random&quot; networks to the true network's topology lacks a relevant reference to Figure 1C, iii</p></disp-quote><p>We thank the reviewer for pointing this out and have now included a reference to Figure 1C, iii.</p><disp-quote content-type="editor-comment"><p>The text introducing the J metric should describe what the indices are, rather than requiring the reader to search the figure.</p></disp-quote><p>In the main text, we have now described what the indices and the corresponding matrix is.</p><disp-quote content-type="editor-comment"><p>The introduction of influence matrix was very hard to follow, the grammar is confusing, and &quot;lmax&quot; is not clearly described in the main text, even though it is used several times.</p></disp-quote><p>We apologize for the confusion caused, and thank the reviewer for pointing it out. We have now expanded on the introduction of influence matrix both in the Materials and methods section and in the main text.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>The authors have now satisfactorily responded to most of the comments/queries.</p><p>Their response to point (6) that I had raised is not entirely satisfactory however, since they do not seem to have addressed the randomization point that I had raised. If random sets of two (or more) genes are chosen for the clustering analysis, how often do we see well separated clusters? It seems to me an important point to analyze and understand, in order to put the ASCL1 and Neurod1 based clustering in perspective. I would strongly urge the authors to include this analysis, unless they feel this is not a sensible question to address, in which case it would be good to hear their arguments against this.</p></disp-quote><p>We thank the reviewer for this constructive comment, and have performed the randomization analysis as well now. We find that the ASCL1-NEUROD1 gene pair is among the top 1% of all possible gene pairs (<sup>33</sup>C<sub>2</sub> = 528) in terms of defining four SCLC phenotypes experimentally reported (Figure 4—figure supplement 3). In other words, approximately 99% of all gene pairs considered here do not offer such well-segregated biologically relevant phenotypic distinction.</p></body></sub-article></article>